: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Breast Cancer

Free Subscription

Articles published in BMC Cancer
Retrieve available abstracts of 472 articles:
HTML format

Single Articles

March 2026

VERDUIN RJT, van den Hurk CJG, van Maurik IS, Nota NM, et al
Interactive symptom monitoring and coaching to optimise toxicity management of chemo(immune)therapy in early stage breast cancer: study protocol of the multicentre randomised controlled eChemoCoach trial.
BMC Cancer. 2026 Mar 26. doi: 10.1186/s12885-026-15905.
PubMed

FAN M, He S, Wan C, Zhang J, et al
Joint synthesis of longitudinal MRI and enhanced prediction of neoadjuvant chemotherapy response in breast cancer: a multicohort study.
BMC Cancer. 2026 Mar 24. doi: 10.1186/s12885-026-15889.
PubMed

GUPTA R, Gopalsamy IK, Nadukkandy AS, Singh A, et al
GCNT3 and ST3GAL1 expression correlates with HER2 status and MUC1/beta-catenin/Cyclin D1 axis in breast cancer.
BMC Cancer. 2026 Mar 19. doi: 10.1186/s12885-026-15821.
PubMed

FATIREGUN OA, Sutradhar R, Podolsky S, Eisen A, et al
Mammographic screening and time to breast cancer diagnosis among immigrants and long-term residents in Ontario.
BMC Cancer. 2026 Mar 19. doi: 10.1186/s12885-026-15693.
PubMed

LIU S, Li Y, Shen Y, Mao Q, et al
Redefining M1: a novel three-tiered classification stratifies prognosis in metastatic breast cancer.
BMC Cancer. 2026 Mar 19. doi: 10.1186/s12885-026-15861.
PubMed

ATTAH DA, Nsaful J, Sefogah PE
Coping with breast cancer in Ghana: a qualitative study of women's lived experiences following breast cancer diagnosis.
BMC Cancer. 2026 Mar 18. doi: 10.1186/s12885-026-15857.
PubMed

AMUJI DN, Iweala EEJ
Association of MET gene polymorphisms with breast cancer risk in Nigerian patients: a case-control study.
BMC Cancer. 2026 Mar 14. doi: 10.1186/s12885-026-15844.
PubMed

ARRARAS JI, Illarramendi JJ, Manterola A, Giesinger JM, et al
The EORTC updated breast cancer quality of life questionnaire EORTC QLQ-BR42: A psychometric study with Spanish patients.
BMC Cancer. 2026 Mar 14. doi: 10.1186/s12885-026-15831.
PubMed

GUO HL, Xie HY, Jiang CL, Weng CF, et al
Surface-guided radiation therapy combined with real-time position management-guided deep inspiratory breath-hold radiotherapy for left breast cancer.
BMC Cancer. 2026 Mar 14. doi: 10.1186/s12885-026-15846.
PubMed

OZCAN D, Nielsen PS, Alsner J, Nielsen MH, et al
Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial.
BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15859.
PubMed

MAVILI HS, Atmis O, Pehlivan FS, Ekinci F, et al
Stromal hypoxia and autophagy signatures as indicators of pathologic response in triple-negative breast cancer.
BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15860.
PubMed

GUCLU T, Tanriverdi O, Bayrakci I, Demir B, et al
Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).
BMC Cancer. 2026 Mar 11. doi: 10.1186/s12885-026-15842.
PubMed

HAO Y, Jiang X, Xiao J, Fan M, et al
Genetic evidence for potential molecular mediators underlying the causal relationship between obesity and breast cancer: a two-step, two-sample Mendelian randomization study.
BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15744.
PubMed Abstract available

GUTIERREZ-GONZALEZ A, Maciel-Cruz EJ, Reynoso-Noveron N, Mohar-Betancourt A, et al
Impact of germline genetic variation on breast cancer prognosis: a systematic review and meta-analysis.
BMC Cancer. 2026 Mar 4. doi: 10.1186/s12885-026-15808.
PubMed

LIU CY, Lin YH, Tsai YF, Lu PY, et al
Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detection.
BMC Cancer. 2026 Mar 3. doi: 10.1186/s12885-026-15741.
PubMed Abstract available

February 2026

UGUZTEMUR E, Dogan M
Tumor-Infiltrating lymphocyte dynamics as biomarkers of neoadjuvant treatment response in luminal breast cancer.
BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15795.
PubMed

FAN Y, Sahoo S, Jolly MK, George JT, et al
Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer.
BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15691.
PubMed

TANG X, Wang T, Shi H, Zhang M, et al
Breast cancer detection using microscopic images based on composition features.
BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-025-15456.
PubMed

EDET B, Sarimiye FO, Essien E, Lu B, et al
A cross-sectional study of coping strategies among a sample of women with breast cancer in South-South, Nigeria.
BMC Cancer. 2026 Feb 19. doi: 10.1186/s12885-026-15770.
PubMed

BROWNSON-SMITH R, Carr J, Orange ST, Cresti N, et al
Longitudinal assessment of chemotherapy-induced peripheral neuropathy in women undergoing taxane-based treatment for breast cancer: a prospective observational study.
BMC Cancer. 2026 Feb 19. doi: 10.1186/s12885-026-15750.
PubMed

DENG Y, Huang W, Zeng T, Gao Y, et al
CDK4/6 inhibitors combined with fulvestrant for the treatment of HR+/HER2-advanced or metastatic breast cancer: a Bayesian network meta-analysis.
BMC Cancer. 2026 Feb 17. doi: 10.1186/s12885-026-15713.
PubMed

HOSSAIN I, Ivy SC, Islam MS, Shahriar M, et al
Evaluation of ERCC4 (XPF) gene rs6498486 polymorphism and its potential role in breast cancer risk among Bangladeshi women.
BMC Cancer. 2026 Feb 17. doi: 10.1186/s12885-026-15739.
PubMed

CONTRERAS-SANCHEZ SE, Doubova SV, Grajales-Alvarez R, Villalobos-Valencia R, et al
Effectiveness of a digital health intervention on the supportive care needs and quality of life in Mexican patients with breast cancer: a randomized clinical trial.
BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15724.
PubMed

LIAO H, Li H, Qu Y, Tang L, et al
IL-8 positive cancer-associated fibroblasts drive breast cancer progression and immune evasion: insights from GWAS and single-cell transcriptomics.
BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15716.
PubMed

AROMAA-HAYHA A, Auvinen P, Malila N, Kataja V, et al
Nonadherence to changing guidelines in early breast cancer over two decades.
BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15731.
PubMed

EL-KHAZRAGY N, Alsolami A, Aref AM, Hassan MNM, et al
MiR-200c restoration inhibits FOXP3 and metastatic spread in breast cancer: evidence from in vitro and in vivo models.
BMC Cancer. 2026 Feb 14. doi: 10.1186/s12885-026-15574.
PubMed Abstract available

ZHANG J, Dai C, Wang S, Chen Y, et al
An evaluation model of chemotherapy efficacy in breast cancer based on combined serum CA15-3, CEA, and CYFRA 21 - 1.
BMC Cancer. 2026 Feb 14. doi: 10.1186/s12885-026-15687.
PubMed Abstract available

OKTEN IN, Baydas T, Koca S, Baltaci MF, et al
Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance.
BMC Cancer. 2026 Feb 13. doi: 10.1186/s12885-026-15721.
PubMed Abstract available

GAO Y, Gong J, Yang Y, Luo Y, et al
Stratified prediction of HER2 status in breast cancer by integrating intratumoral and peritumoral radiomics from DCE-MRI.
BMC Cancer. 2026 Feb 13. doi: 10.1186/s12885-026-15688.
PubMed

KUBECZKO M, Polakiewicz-Gilowska A, Swiderska K, Mianowska-Malec M, et al
Deciphering the role of Ki67: prognostic insights in advanced breast cancer therapy with Cyclin-dependent kinase 4/6 inhibitors.
BMC Cancer. 2026 Feb 13. doi: 10.1186/s12885-026-15594.
PubMed

MAYBERRY SA, Hsu PC, Lin HY, Rogers LJ, et al
Association of DNA methyltransferase polymorphisms with breast cancer: a nested case?control study of the Arkansas Rural Community Health study.
BMC Cancer. 2026 Feb 10. doi: 10.1186/s12885-026-15695.
PubMed

ZHANG L, Sun F, Wang X, Zhao W, et al
Efficacy and safety of treatments in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor progression: a network meta-analysis and scoping review.
BMC Cancer. 2026 Feb 7. doi: 10.1186/s12885-026-15632.
PubMed

OZTURK HA, Koc M, Okyay RA, Ozturk DD, et al
Cardioprotective effects of dapagliflozin against doxorubicin-induced cardiotoxicity in breast cancer patients with type 2 diabetes: a prospective study.
BMC Cancer. 2026 Feb 7. doi: 10.1186/s12885-026-15696.
PubMed Abstract available

CAMPONE M, Frenel JS, Kiver VII, Woeckel A, et al
Treatment patterns and clinical outcomes in chemotherapy-treated patients with HR+/HER2- metastatic breast cancer using real-world data in France and Germany.
BMC Cancer. 2026 Feb 3. doi: 10.1186/s12885-026-15611.
PubMed

January 2026

SAFAVI A, Mohammadzadeh N, Kaviani A, Dadashi A, et al
Axillary staging in post-neoadjuvant chemotherapy breast cancer patients: prognostic analysis and validation of axillary nodal metrics and comparison of pathological node staging versus the lymph node ratio systems in a 169-case series.
BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15564.
PubMed

BRANDSTETTER LS, Grau A, Muller-Reiter M, Salmen J, et al
Medication adherence in a German cohort of patients with advanced or metastatic breast cancer: results of the BRE-BY-MED study.
BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15641.
PubMed

TAO R, Liu B, Gao S, Zhang J, et al
The role of CD26 in breast cancer and its pan-cancer analysis.
BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15656.
PubMed Abstract available

WOOF VG, Howell A, Fox L, McWilliams L, et al
How do women experience a change in their clinically-derived breast cancer risk estimates: views from a UK family history risk and prevention clinic.
BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15651.
PubMed Abstract available

AWADA Z, Kazmi N, Jones HJ, Lewis SJ, et al
The causal association between systolic blood pressure and breast cancer: a two sample Mendelian randomization study.
BMC Cancer. 2026 Jan 22. doi: 10.1186/s12885-025-15513.
PubMed

FENG L, Liang Y, Huang J, Xu S, et al
Evaluation of organs at risk (OARs) in whole-breast irradiation: a comparison of prone, supine position and with deep inspiration breath-hold techniques-subgroup analysis from a prospective study.
BMC Cancer. 2026;26:307.
PubMed Abstract available

CAZZANIGA ME, Galimberti S, Pepe FF, Cogliati V, et al
Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study.
BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-025-15482.
PubMed

AIKELAIMU A, Li W, Kaicaier M, Liu S, et al
Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy in breast cancer: a systematic review and meta-analysis with focus on triple-negative subtype and immune-related adverse events.
BMC Cancer. 2026 Jan 19. doi: 10.1186/s12885-025-15521.
PubMed

ELALFY E, Gaber NE, Helmy MH, Kamel MA, et al
Scrutinizing the potential role of non-coding RNAs as biomarkers in Egyptian females with early and metastatic breast cancer.
BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-025-15483.
PubMed

CHEKHUN V, Lukianova Y, Mushii O, Zadvornyi T, et al
Breast cancer microenvironment composition associated with high PD-L1 expression.
BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15542.
PubMed Abstract available

ZHANG C, Li S, Ren J, Wen X, et al
Optimizing ribociclib dosing in breast cancer with brain metastasis patients using a physiologically based pharmacokinetic model.
BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-026-15561.
PubMed

CHOUDHARY A, Poojary SS, Jain P, Chaturvedi H, et al
Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of triple negative breast cancer.
BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-025-15499.
PubMed Abstract available

SHI QF, Hu PF, Liu YH
Ultrasound for predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis.
BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-026-15545.
PubMed Abstract available

PETER M, Swaminathan N, Govindharaj P
Development of culture specific quality of life tool for breast cancer survivors of Indian population.
BMC Cancer. 2026 Jan 10. doi: 10.1186/s12885-026-15563.
PubMed Abstract available

ADAMSON B, van Boemmel-Wegmann S, Horne E, Soares S, et al
Real-world evidence from Germany: representativeness analysis and mortality endpoint validation in electronic health record-derived oncology cohorts.
BMC Cancer. 2026;26:202.
PubMed Abstract available

HUNDAL J, Williams D, Nock NL, Austin K, et al
Older breast cancer survivors' exercise and support group program experiences and recommendations from the IMPROVE trial: a qualitative study.
BMC Cancer. 2026 Jan 6. doi: 10.1186/s12885-025-15425.
PubMed Abstract available

YOON TI, Baek S, Lee JH, Yoo TK, et al
Clinical significance of peripheral blood parameters as a prognostic biomarker in patients receiving neoadjuvant chemotherapy for breast cancer.
BMC Cancer. 2026 Jan 3. doi: 10.1186/s12885-025-15510.
PubMed

December 2025

LV M, Liu Y, Cao W, Wang Y, et al
Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer.
BMC Cancer. 2025 Dec 30. doi: 10.1186/s12885-025-15500.
PubMed Abstract available

NAFISSI N, Rezazadeh M, Kheradpishe A, Radkhah H, et al
Diagnostic value of peripheral blood inflammatory indices for breast cancer grade and immunohistochemical markers: a retrospective observational study.
BMC Cancer. 2025;25:1886.
PubMed Abstract available

WEI C, Zhou S, Zhu L, Kong J, et al
Comparison of the efficacy between radiotherapy alone and surgery plus radiotherapy for ipsilateral supraclavicular lymph node metastasis in breast cancer based on propensity score matching analysis: a retrospective study with 8-year follow-up.
BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15424.
PubMed

CHEN BA, Qin WH, Chen HB, Yang QH, et al
The effect of exercise intervention on IGF axis and metabolic markers regulation in breast cancer patients: a systematic review with pairwise, network, and dose-response meta-analyses.
BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15475.
PubMed

MASHAYEKH Z, Fard RF, Vallian S
Noncoding RNAs and DNA methylation as epigenetic modulators of breast cancer: mechanisms and clinical perspectives in the Iranian population, a systematic review.
BMC Cancer. 2025 Dec 20. doi: 10.1186/s12885-025-15430.
PubMed

ALHALABI A, Abdo T, Hijazi A, Mohanna M, et al
Factors associated with developing and surviving brain metastases in patients with breast cancer: a multi-center experience.
BMC Cancer. 2025 Dec 19. doi: 10.1186/s12885-025-15422.
PubMed Abstract available

HEIDINGER M, Staehelin S, Halbeisen FS, Maggi N, et al
Impact of bilateral surgery on time to treatment in patients with breast cancer undergoing mastectomy - a retrospective cohort study.
BMC Cancer. 2025 Dec 19. doi: 10.1186/s12885-025-15389.
PubMed Abstract available

XIE H, Zhang J, Li Q, Tan T, et al
Enhancing breast cancer diagnosis: non-invasive prediction of MKI-67 (Ki67) expression using ultrasound images.
BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15443.
PubMed Abstract available

YILMAZ S, Yur M
CA 15 - 3 may be a promising biomarker for differentiating distant organ metastasis in breast cancer at initial diagnosis.
BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15463.
PubMed Abstract available

ANDRADE DC, Parrish L, Harriss C, Peterson LL, et al
A qualitative exploration of patient and clinician needs and preferences for a physical activity intervention during breast cancer chemotherapy.
BMC Cancer. 2025 Dec 12. doi: 10.1186/s12885-025-15342.
PubMed Abstract available

FESSI Z, Bonnier S, Lodyga K, Wallet J, et al
Stereotactic re-irradiation for lymph node recurrence of breast cancer.
BMC Cancer. 2025 Dec 8. doi: 10.1186/s12885-025-15418.
PubMed

HUANG H, Chen X, Wang Z, Zhang Y, et al
Evidence-based prescription: optimal exercise type and dose for pain management in breast cancer survivors-a systematic review and dose-response network meta-analysis.
BMC Cancer. 2025 Dec 6. doi: 10.1186/s12885-025-15432.
PubMed Abstract available

YANG Y, Ma Y, Xue F, Li J, et al
Using single-cell and transcriptome data to identify prognostic genes associated with SUMO-ylation and their molecular regulatory mechanisms in breast cancer.
BMC Cancer. 2025 Dec 6. doi: 10.1186/s12885-025-15265.
PubMed Abstract available

ALLSOPP RC, Page K, Wren E, Nteliopoulos G, et al
Concurrent genomic assessment of circulating tumour cells and ctDNA to guide therapy in metastatic breast cancer.
BMC Cancer. 2025;25:1858.
PubMed Abstract available

CAGDAS EK, Cagdas B
LYN mutations in breast cancer: hypothesis-generating evidence for an association with central nervous system metastasis and domain-level insights.
BMC Cancer. 2025 Dec 5. doi: 10.1186/s12885-025-15398.
PubMed Abstract available

SARFRAZ Z, Ozair A, Bardhan M, Starosciak AK, et al
Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial.
BMC Cancer. 2025 Dec 4. doi: 10.1186/s12885-025-15224.
PubMed Abstract available

SPERK E, Lemanski C, Neumaier C, Lauer J, et al
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E.
BMC Cancer. 2025;25:1862.
PubMed Abstract available

JENKINSON NM, Hughes S, Baras A, Meeker A, et al
Context-dependent MAN1A1 protein expression in metastatic breast cancer progression predicts patient survival.
BMC Cancer. 2025 Dec 1. doi: 10.1186/s12885-025-15380.
PubMed Abstract available

DU R, Qian R, Qin R, Yu Y, et al
Gradient perfusion features can effectively identify sentinel lymph node metastasis in early breast cancer.
BMC Cancer. 2025 Dec 1. doi: 10.1186/s12885-025-15251.
PubMed

PETER J, Jolly B, Raha R, Jothi J, et al
Germline mutational landscape in a large cohort of Indian breast cancer.
BMC Cancer. 2025 Dec 1. doi: 10.1186/s12885-025-15360.
PubMed

November 2025

LIU C, Wang R, Wang S, Liu S, et al
Pregnancy-associated breast cancer: gestational weight gain impact and nomogram validation.
BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15292.
PubMed Abstract available

RANTALA J, Seppa K, Eriksson J, Heinavaara S, et al
Associations between modifiable factors and early-onset breast cancer mortality among patients.
BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15226.
PubMed Abstract available

BAS O, Inci BK, Eroglu I, Efil SC, et al
Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.
BMC Cancer. 2025;25:1831.
PubMed Abstract available

HAFEEZ A, Basit M, Zafar S, Shabbir M, et al
Comprehensive analysis of gene expression alterations in breast cancer patients via PKCtheta-TBK1-mTORC1 signaling pathway.
BMC Cancer. 2025;25:1844.
PubMed Abstract available

TAKADA K, Kashiwagi S, Nishikawa M, Kochi A, et al
Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs).
BMC Cancer. 2025 Nov 28. doi: 10.1186/s12885-025-15255.
PubMed Abstract available

MARICIC VRBAN M, Radovani Trbojevic B, Visentin D, Ramljak K, et al
Therapy-induced remodeling of IgG and plasma N-glycans in breast cancer.
BMC Cancer. 2025 Nov 27. doi: 10.1186/s12885-025-15381.
PubMed Abstract available

LI J, Liu J, Cai B, Yang C, et al
Association of estimated glucose disposal rate with all-cause and breast cancer-specific mortality in US breast cancer survivors: a population-based study.
BMC Cancer. 2025 Nov 27. doi: 10.1186/s12885-025-15340.
PubMed Abstract available

PINCHAS-MIZRACHI R, Bouhnik D
Correction: The parity paradox: does number of children (parity) influence breast cancer mortality across the life course?
BMC Cancer. 2025;25:1830.
PubMed

SPERLICH S, Geyer S, Holthausen-Markou S, Park-Simon TW, et al
Breast cancer survivors' participation in social activities five years after primary surgery - are there social inequalities?
BMC Cancer. 2025;25:1829.
PubMed Abstract available

COELHO LL, Vianna MM, da Silva DM, Gonzaga BMS, et al
beta-lapachone impairs viability, migration, and epithelial-mesenchymal transition in mammary tumor spheroids.
BMC Cancer. 2025;25:1826.
PubMed Abstract available

DENG Z, Li Y, Luo Y, Cao X, et al
Nomogram models for prediction of axillary lymph node metastasis in breast cancer patients.
BMC Cancer. 2025;25:1827.
PubMed Abstract available

YUAN S, Li J, Liu W, Ren M, et al
CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis.
BMC Cancer. 2025;25:1828.
PubMed Abstract available

SALARI Z, Khosravi A, Riahi A, Molaakbari E, et al
Niosomal mefloquine and cisplatin in breast cancer: comparative effects on apoptosis and angiogenesis via in vitro and in silico analysis.
BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15372.
PubMed Abstract available

WU F, Xu F, He J, Hu H, et al
Reducing breast biopsy at MRI: comparison of minimum ADC cutoff and mean ADC cutoff identified by the ECOG-ACRIN A6702 multicenter trial.
BMC Cancer. 2025;25:1938.
PubMed Abstract available

MALAWARAARACHCHI BP, Abeysinghe C, Seneviwickrama M, Ranasinghe S, et al
Body image concerns among women diagnosed with breast cancer in a South Asian setting: a phenomenology approach.
BMC Cancer. 2025;25:1819.
PubMed Abstract available

OJEDELE OA, Hamdi N, Mughram MHA, Alyami EM, et al
Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling.
BMC Cancer. 2025;25:1812.
PubMed Abstract available

ZHANG H, Yin X, Wang S, Li Q, et al
Combined elevation of myeloid-derived suppressor cells and Tregs predicts lymph node metastasis in breast cancer.
BMC Cancer. 2025;25:1806.
PubMed Abstract available

YAN X, Zhang X, Wang Z, Yang L, et al
Safety and efficacy of immune checkpoint inhibitors in patients with triple-negative breast cancer: a systematic review and meta-analysis.
BMC Cancer. 2025;25:1804.
PubMed Abstract available

DELABY C, Al Herk A, Hirtz C, Jacot W, et al
Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer.
BMC Cancer. 2025;25:1801.
PubMed Abstract available

SHAWANA S, Mirza T, Khatoon A, Mushtaq S, et al
Uncovering rare somatic variants in olfactory receptor genes in Pakistani triple-negative breast cancer patients.
BMC Cancer. 2025;25:1799.
PubMed Abstract available

WANG A, Zeng P, Ma T, Shi H, et al
Establishment of a new method for detection of TROP2-positive circulating tumor cells in breast cancer.
BMC Cancer. 2025;25:1797.
PubMed Abstract available

YU S, Wu J
CTHRC1-driven breast cancer progression: insights from palmitoylation networks and spatial heterogeneity.
BMC Cancer. 2025;25:1795.
PubMed Abstract available

CHEN Q, Xiong J, Wang H, Xu Y, et al
A nomogram for breast cancer brain metastasis patients after stereotactic radiotherapy.
BMC Cancer. 2025;25:1784.
PubMed Abstract available

FANG Q, Sanderson RW, Zilkens R, Boman I, et al
Diagnostic feasibility study of stereoscopic optical palpation for breast tumour margin assessment.
BMC Cancer. 2025;25:1793.
PubMed Abstract available

LOZA P, Irmejs A, Daneberga Z, Maksimenko J, et al
The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer.
BMC Cancer. 2025;25:1769.
PubMed Abstract available

ZHANG Y, Cai J, Cui C, Qi S, et al
Predicting breast cancer response to neoadjuvant therapy by integrating radiomic and deep-learning features from early-and-peak phases of DCE-MRI.
BMC Cancer. 2025;25:1747.
PubMed Abstract available

MIZRACHI RP, Bouhnik D
The parity paradox: does number of children (parity) influence breast cancer mortality across the life course?
BMC Cancer. 2025;25:1750.
PubMed Abstract available

MONKAM P, Wang X, Zhao B, Qi S, et al
Efficient temporal feature utilization in ultrasound videos: a multi-channel deep learning framework for enhanced breast lesion differentiation.
BMC Cancer. 2025;25:1744.
PubMed Abstract available

SECA M, Gronwald J, Huzarski T, Glass K, et al
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study.
BMC Cancer. 2025;25:1740.
PubMed Abstract available

LIU J, Leng X, Yuan Z, Li Y, et al
Predicting breast cancer response to neoadjuvant chemotherapy with ultrasound-based deep learning radiomics models -- dual-center study.
BMC Cancer. 2025;25:1737.
PubMed Abstract available

VENGHATERI JB, Nathani P, Goyal S, Sarang B, et al
Low participation in cancer screening in India: a scoping review of breast and cervical cancer programs.
BMC Cancer. 2025;25:1724.
PubMed Abstract available

OSHINO T, Shimizu H, Sato M, Nishida M, et al
Impact of breast tumor size discrepancy between contrast-enhanced and conventional ultrasonography on axillary node metastasis: a retrospective cohort study.
BMC Cancer. 2025;25:1718.
PubMed Abstract available

TOKUR O, Aydin S, Kilinc F, Degirmenci T, et al
Diagnostic value of super microvascular imaging in differentiating axillary lymph nodes: semi-quantitative and qualitative approach in primary breast cancer and suspicious axillary nodes.
BMC Cancer. 2025;25:1705.
PubMed Abstract available

IMAMURA S, Mori K, Yasojima H, Mizutani M, et al
Genomically determined subtypes and clinicopathological features as predictors of the efficacy of preoperative chemotherapy combined with HER2-targeted therapy for early-stage HER2-positive breast cancer.
BMC Cancer. 2025;25:1707.
PubMed Abstract available

October 2025

ELSNER SA, Haussmann E, Grieger P, Hadwiger M, et al
Optimising breast cancer screening in national mammography screening centres: challenges and insights on implementing additional ultrasound for women with dense breast tissue - a qualitative study.
BMC Cancer. 2025;25:1684.
PubMed

ZAFAR S, Badshah Y, Shabbir M, Khan S, et al
Comprehensive computational analysis of PKCdelta non-synonymous variants identifies rs1703863535 as a potential breast cancer biomarker.
BMC Cancer. 2025;25:1667.
PubMed Abstract available

TOMCZIK K, Niznik J, Coombs LA
"Who's gonna take care of my babies?" the impact of children on treatment decisions for women with metastatic breast cancer: a qualitative analysis.
BMC Cancer. 2025;25:1662.
PubMed Abstract available

RE F, Manaboriboon N, Raza IGA, Shipley A, et al
A systematic review of prediction models for risk of breast cancer.
BMC Cancer. 2025;25:1650.
PubMed Abstract available

AMIN A, U DA, Koteshwara P, P C S, et al
A systematic literature review on mammography: deep learning techniques for breast cancer detection with global and Asian perspectives.
BMC Cancer. 2025;25:1627.
PubMed Abstract available

SONG Z, Ding M, Zang Q, Wang L, et al
Association of reproductive and menstrual factors with the risk of breast cancer in women: a population-based study.
BMC Cancer. 2025;25:1621.
PubMed Abstract available

DERISMAHAFI Z, Farhud D, Razavirad A, Muhammadnejad A, et al
NRF2 expression level and estrogen function in BRCA1-mutated breast cancer.
BMC Cancer. 2025;25:1622.
PubMed Abstract available

LI Y, Zhang Z, Liu X, Cheng Y, et al
Integrative analysis identifies radiotherapy resistance-associated CAF subtypes shaping the tumor immune landscape in breast cancer.
BMC Cancer. 2025;25:1603.
PubMed Abstract available

GUO X, Gong X, Yang Y, Wang L, et al
Circumferential periareolar incision length as a risk factor for skin necrosis after nipple-sparing mastectomy with deep inferior epigastric perforator flap reconstruction.
BMC Cancer. 2025;25:1592.
PubMed Abstract available

LI Y, Long X, Xie Y, Zhong X, et al
Tropomodulin 1 is essential for chemotherapy sensitivity and associated with better outcome in triple-negative breast cancer.
BMC Cancer. 2025;25:1594.
PubMed Abstract available

SHARMA A, Johnson KB, Sen A, Bie B, et al
Longitudinal multi-omics analyses of chemotherapy-induced peripheral neuropathy in response to taxanes.
BMC Cancer. 2025;25:1591.
PubMed Abstract available

LI L, Yang P, Hong C, Chen D, et al
Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response and prognosis in breast cancer: a multicenter retrospective study based on Chinese population.
BMC Cancer. 2025;25:1585.
PubMed Abstract available

YAO G, Huang Y, Shang X, Guo L, et al
Prediction of intraductal cancer microinfiltration based on the hierarchical fusion of peri-tumor imaging histology and dual view deep learning.
BMC Cancer. 2025;25:1564.
PubMed Abstract available

OKAZAKI M, Ueda A, Iguchi-Manaka A, Mathis BJ, et al
Refining compression therapy for the prevention of chemotherapy-induced peripheral neuropathy in breast cancer patients: a sub-analysis of patient-reported discomfort and usability.
BMC Cancer. 2025;25:1567.
PubMed Abstract available

COSTA-PEREIRA JP, Macedo IF, Barbosa GA, Leitao GM, et al
Myosteatosis is associated with advanced TNM stage and tumor features in young females with breast cancer.
BMC Cancer. 2025;25:1576.
PubMed Abstract available

SCHAGERHOLM STANEV C, Sifakis EG, Hases L, Chen X, et al
Transcriptomic profiles of endocrine-resistant breast cancer.
BMC Cancer. 2025;25:1556.
PubMed Abstract available

SIMONYAN RM, Babayan MA, Yekmalyan HH, Simonyan SG, et al
Thermostable enzyme isoforms, continuously producing monocomponent superoxide radicals, from human postoperative serous fluids: isolation and properties.
BMC Cancer. 2025;25:1555.
PubMed Abstract available

LIU Y, Ren T, Chen X, He Q, et al
Comparative efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy in HR+/HR2- patients with advanced or metastatic breast cancer: a systematic review and network meta-analysis.
BMC Cancer. 2025;25:1535.
PubMed

TAKADA K, Kashiwagi S, Nishikawa M, Kochi A, et al
Differences in Sentinel lymph node biopsy outcomes and prognosis between HER2-low and HER2-zero breast cancer.
BMC Cancer. 2025;25:1518.
PubMed Abstract available

VARGHESE D, Collins J, Nordstrom B, Miranda M, et al
Epidemiology and outcomes associated with brain metastases among patients with metastatic breast cancer - a cohort study in US electronic health record data.
BMC Cancer. 2025;25:1475.
PubMed Abstract available

HOSSEINI SS, Askari N, Yaghoobi MM
Combined anti-tumor effects of metformin and azacitidine in breast cancer cells.
BMC Cancer. 2025;25:1487.
PubMed Abstract available

AFAYA A, Lee H, Kim SY, Park CG, et al
Multilevel factors associated with clinical breast examination uptake among women in the Northern Region of Ghana: a cross-sectional survey.
BMC Cancer. 2025;25:1476.
PubMed Abstract available

KORANTZIS I, Koumarianou A, Rapti V, Timotheadou E, et al
Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study).
BMC Cancer. 2025;25:1473.
PubMed Abstract available

September 2025

AL-TAJ MA
Sweets consumption and breast cancer risk among women in yemen: a matched case control study.
BMC Cancer. 2025;25:1495.
PubMed Abstract available

WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
BMC Cancer. 2025;25:1469.
PubMed Abstract available

CHEN X, Cheng Z, Li Y, Wu X, et al
Development and validation of a machine learning model to predict delays in seeking medical care among patients with breast cancer in China.
BMC Cancer. 2025;25:1442.
PubMed Abstract available

ZHOU J, Liang B, Su M, Zhang Z, et al
Long-term exposures to PM(2.5) components increase the breast cancer mortality in the region of Inner Mongolia, China: a retrospective study based on mixture cure model.
BMC Cancer. 2025;25:1465.
PubMed Abstract available

DURRANI S, Al-Ghamdi AA, Al-Bugawi A, Al-Khammash A, et al
Prognostic factors and survival outcome of brain metastases in breast cancer patients: a retrospective analysis.
BMC Cancer. 2025;25:1455.
PubMed Abstract available

YAHYAPOUR A, Askari N, Yaghoobi MM
Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells.
BMC Cancer. 2025;25:1427.
PubMed Abstract available

JANG MK, Park S, Jeon JY, Kang MJ, et al
Correction: Evaluating the effects of a resistance exercise intervention for sarcopenia in patients receiving neoadjuvant chemotherapy for breast cancer: study protocol for a randomized controlled trial.
BMC Cancer. 2025;25:1422.
PubMed

August 2025

YANG Y, Zhao Y, Yao K, Li W, et al
The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients.
BMC Cancer. 2025;25:1403.
PubMed Abstract available

KURANT DE, Groha S, Ding Y, German C, et al
Association between polygenic risk and survival in breast cancer patients.
BMC Cancer. 2025;25:1393.
PubMed

LI JD, Deng LL, Luo JY, Mo CH, et al
The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective.
BMC Cancer. 2025;25:1363.
PubMed Abstract available

ARAUJO CFM, Nunes LC, Murta-Nascimento C, Bragagnoli AC, et al
Metformin for the treatment of breast cancer: a scoping review of randomized clinical trials.
BMC Cancer. 2025;25:1352.
PubMed Abstract available

WANG Y, Wang L, Yu B, Wen S, et al
Global, regional, and national burden of male breast cancer and predictions in the next 30 years: a systematic analysis of the global burden of disease study 2021.
BMC Cancer. 2025;25:1344.
PubMed Abstract available

LIAN W, Li L, Hong C, Chen D, et al
Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study.
BMC Cancer. 2025;25:1331.
PubMed Abstract available

SREENATH ND, Pandalanghat S, Kapoor A, Govind R, et al
A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort.
BMC Cancer. 2025;25:1337.
PubMed Abstract available

TAIWO R, Harary PM, Trinh TTH, Granucci M, et al
Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases.
BMC Cancer. 2025;25:1316.
PubMed Abstract available

LI SY, Li YM, Fang YQ, Jin ZY, et al
Contrast-enhanced ultrasound radiomics model for predicting axillary lymph node metastasis and prognosis in breast cancer: a multicenter study.
BMC Cancer. 2025;25:1315.
PubMed Abstract available

QIN JN, Dai WB, Zhang WH, Chen BJ, et al
Identification of optimal biomarkers associated with distant metastasis in breast cancer using Boruta and Lasso machine learning algorithms.
BMC Cancer. 2025;25:1311.
PubMed Abstract available

MARIOSA D, Ponzano M, Grotta A, Lagerros YT, et al
Dietary non-enzymatic antioxidant capacity and risk of breast cancer: the Swedish National March Cohort.
BMC Cancer. 2025;25:1310.
PubMed Abstract available

FU J, Deng S, Zheng W, Zheng C, et al
Construction of a transfer learning-based depression detection model for female breast cancer patients: text sentiment analysis.
BMC Cancer. 2025;25:1307.
PubMed Abstract available

XING B, Gu C, Fu C, Zhang B, et al
Diagnostic performance of ultrasound S-Detect technology in evaluating BI-RADS-4 breast nodules 20 mm.
BMC Cancer. 2025;25:1306.
PubMed Abstract available

LEE J, Ahn HK, Lee KH, Jung KH, et al
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemother
BMC Cancer. 2025;25:1295.
PubMed Abstract available

JANG MK, Park S, Jeon JY, Kang MJ, et al
Evaluating the effects of a resistance exercise intervention for sarcopenia in patients receiving neoadjuvant chemotherapy for breast cancer: study protocol for a randomized controlled trial.
BMC Cancer. 2025;25:1296.
PubMed Abstract available

OLSON R, Cua M, Matthews Q, Laing J, et al
Phase II single vs hypofractionated irradiation for timely access to partial breast radiotherapy (SHIFT-PB).
BMC Cancer. 2025;25:1285.
PubMed Abstract available

SAROOSH R, Ahmad N, Israr B, Nazir A, et al
Association of diabetes mellitus and breast cancer in adult men and women: a cross-sectional survey.
BMC Cancer. 2025;25:1276.
PubMed Abstract available

TAFESE AM, Fentie MT, Seifu BL, Asnake AA, et al
Breast cancer survival rates and determinants in Ethiopia: a systematic review and meta-analysis of longitudinal studies.
BMC Cancer. 2025;25:1263.
PubMed Abstract available

AL-MASRI M, Aljalabneh B, AlMasri R, Alayyan O, et al
Comparative survival analysis of HER2-positive Pregnancy-Associated Breast Cancer (PABC) and non-Pregnancy-Associated breast Cancer (non-PABC) cohorts: a matched control study.
BMC Cancer. 2025;25:1252.
PubMed Abstract available

July 2025

LUO L, Zhang X, Chen L, Chen Z, et al
Dual-targeting and steric hindrance resolution in HER2 IHC: a novel approach to improve diagnostic sensitivity.
BMC Cancer. 2025;25:1231.
PubMed Abstract available

WANG W, Wu B, Li J, Shang Y, et al
The application and predictive value of the weight-adjusted-waist index in BC prevalence assessment: a comprehensive statistical and machine learning analysis using NHANES data.
BMC Cancer. 2025;25:1234.
PubMed Abstract available

SHARIATMADARI H, Taheri-Kharameh Z, Kamaliuon N, Ghanbari Hashem Abadi BA, et al
Comparing the effectiveness of gratitude intervention and behavioral activation technique in breast cancer patients: a randomized trial.
BMC Cancer. 2025;25:1226.
PubMed Abstract available

SUN Q, Hu J, Ye Y, Ma L, et al
The effect of smoking on breast cancer screening results in female population: a study in Wu wei, China.
BMC Cancer. 2025;25:1225.
PubMed Abstract available

EKDAHL HJELM T, Gebremariam TY, Weldearegay MF, Sori M, et al
Stage at diagnosis and tumor characteristics among young women and men with breast cancer, in Ethiopia and Sweden, a descriptive cross-sectional study.
BMC Cancer. 2025;25:1222.
PubMed Abstract available

CHAI C, Shao K, Shan G, Li P, et al
Dosimetric study of TrueBeam single-isocenter vs. Halcyon dual-isocenter VMAT radiotherapy plans for postoperative left-sided breast cancer.
BMC Cancer. 2025;25:1214.
PubMed Abstract available

ZHOU X, Wang Y, Xu Q, Ao X, et al
BALs are prognostic biomarkers and correlate with malignant behaviors in breast cancer.
BMC Cancer. 2025;25:1205.
PubMed Abstract available

KING J, Fakhouri W, Jarvis R, Badreldin W, et al
Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study.
BMC Cancer. 2025;25:1189.
PubMed Abstract available

NASIR J, Han B, Hu X, Ling H, et al
Retrospective insights: clinical characteristics and survival in 403 ILC cases from China.
BMC Cancer. 2025;25:1188.
PubMed Abstract available

YANG L, Li Y, Zeng T, Long M, et al
Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study.
BMC Cancer. 2025;25:1163.
PubMed Abstract available

WANG S, Liu J, Song L, Zhao H, et al
Integrative multimodal ultrasound and radiomics for early prediction of neoadjuvant therapy response in breast cancer: a clinical study.
BMC Cancer. 2025;25:1156.
PubMed Abstract available

LLEVENES P, Chen A, Lawton M, Rondon-Ortiz AN, et al
Plasma exosomes in insulin resistant obesity exacerbate progression of triple negative breast cancer.
BMC Cancer. 2025;25:1089.
PubMed Abstract available

MOHEBBI A, Asli F, Mohammadzadeh S, Ardakani AA, et al
Exploring the role of tumor to background parenchymal ratio of the [18F]FLT PET/CT measures in determining response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
BMC Cancer. 2025;25:1139.
PubMed Abstract available

OSBORNE A
Sex-disaggregated analysis of breast cancer prevalence in Sierra Leone.
BMC Cancer. 2025;25:1022.
PubMed Abstract available

HENDY A, Ibrahim RK, Darwish A, Al Sabbah S, et al
Sleep disturbance, cancer-related fatigue, and depression as determinants of quality of life among breast cancer patients undergoing chemotherapy: a cross-sectional study.
BMC Cancer. 2025;25:1122.
PubMed Abstract available

DANG C, Wang R, Shi Y, Liu P, et al
Genetically proxied therapeutic effect of antihypertensive drug use, breast cancer, and ovarian cancer's risk: a drug-target Mendelian randomization study.
BMC Cancer. 2025;25:1125.
PubMed Abstract available

GUO Q, Wu P, He J, Zhang G, et al
Machine learning algorithms predict breast cancer incidence risk: a data-driven retrospective study based on biochemical biomarkers.
BMC Cancer. 2025;25:1061.
PubMed Abstract available

LU Z, Yang J, Feng Y, Ming J, et al
Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.
BMC Cancer. 2025;25:1048.
PubMed Abstract available

CHEANG I, Gue Y, Wu MZ, Huang JY, et al
Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study.
BMC Cancer. 2025;25:1063.
PubMed Abstract available

LIAN J, Yao R, Xu Y, Tan L, et al
Prediction of the 70-gene signature (MammaPrint) high versus low risk by nomograms among axillary lymph node positive (LN+) and negative (LN-) Chinese breast cancer patients, a retrospective study.
BMC Cancer. 2025;25:1128.
PubMed Abstract available

WANG C, Xiao D, Zhai C
Efficacy and safety of small-molecule TKIs in neoadjuvant treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
BMC Cancer. 2025;25:1072.
PubMed Abstract available

SALLAUKA R, Horvat M, Ravnik M, Rashwan H, et al
Scoping review: (Bio)markers for the prognostication of breast cancer recurrence.
BMC Cancer. 2025;25:1081.
PubMed Abstract available

ANWAR E, Amjad A, Zubairi AJ, Ali MM, et al
De Novo bone metastasis in breast cancer: tumor biology and survival outcomes in a retrospective study from Pakistan.
BMC Cancer. 2025;25:1074.
PubMed Abstract available

CIVIL YA, Duvivier KM, Bartels SAL, Velde SV, et al
Impact of neoadjuvant systemic therapy on surgical and radiotherapy outcomes in patients with early-stage breast cancer: a cross-sectional retrospective single-center study.
BMC Cancer. 2025;25:1046.
PubMed Abstract available

DEBELA MB, Gonfa KB, Hussen MM, Zenbaba D, et al
Breast cancer determinants in low- to upper-middle-income countries: an umbrella review of meta-analyses of observational studies and an urgent call for implementation science.
BMC Cancer. 2025;25:1096.
PubMed Abstract available

CAREW JW, Radulescu SC, Zhang L, Ungurean C, et al
Breast cancer mortality in Romania: trends, regional and rural-urban inequalities, and policy implications.
BMC Cancer. 2025;25:1038.
PubMed Abstract available

HAFEEZ A, Shabbir M, Badshah Y, Farooq A, et al
Association of PRKCQ variants with breast cancer susceptibility and clinicopathological features.
BMC Cancer. 2025;25:1069.
PubMed Abstract available

ZENG Y, Liu R, Rong L
Predictive value of androgen receptor in distant metastasis of triple-negative breast cancer: a retrospective multi-center study.
BMC Cancer. 2025;25:1115.
PubMed Abstract available

MARTI-DIAZ R, Sanchez-Del-Campo L, Montenegro MF, Hernandez-Caselles T, et al
Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine.
BMC Cancer. 2025;25:1029.
PubMed Abstract available

SHIAU JP, Yang CW, Liu W, Yu SY, et al
Excavatolide C has oxidative-stress-dependent antiproliferative and apoptotic effects against breast cancer cells.
BMC Cancer. 2025;25:1023.
PubMed Abstract available

COSTANZO S, Godino L, De Summa S, Marvulli TM, et al
BRCA cascade counselling and testing in Italy: current position and future directions.
BMC Cancer. 2025;25:1044.
PubMed Abstract available

June 2025

WANG W, Sun Y, Li J, Bai H, et al
Global, regional, and national burden of breast cancer in young women from 1990 to 2021: findings from the global burden of disease study 2021.
BMC Cancer. 2025;25:1015.
PubMed Abstract available

EBRAHIM NAA, Hussein MA, Sobeih ME, Amin NH, et al
From biomarker to targeted therapy: investigating trophoblast cell-surface antigen 2 expression in triple-negative breast cancer- insights from the national cancer institute.
BMC Cancer. 2025;25:1008.
PubMed Abstract available

EL-JAMMAL M, Saifi O, Bazan J, Zeidan YH, et al
Radiation therapy in clinically node positive HER2 positive breast cancer after primary systemic therapy and breast conserving surgery: pooled analysis of TRYPHAENA and NeoSphere trials.
BMC Cancer. 2025;25:996.
PubMed Abstract available

KARIMI MA, Khadem R, Haraj A, Farahani MA, et al
The impact of sodium-glucose cotransporter-2 inhibitors on breast cancer and cancer-related mortality: a systematic review and meta-analysis of randomized controlled trials.
BMC Cancer. 2025;25:991.
PubMed Abstract available

OSBORNE A, Adnani QES, Ahinkorah BO
Breast cancer incidence in Indonesia: a sex-disaggregated analysis using WHO health equity assessment toolkit data.
BMC Cancer. 2025;25:986.
PubMed Abstract available

LIANG Y, Xu H, Lin J, Tang W, et al
Multi-modal radiomics model based on four imaging modalities for predicting pathological complete response to neoadjuvant treatment in breast cancer.
BMC Cancer. 2025;25:985.
PubMed Abstract available

BREEK K, Abuhalima D, Salameh H, Al-Jabi SW, et al
Self-reported side effects of breast cancer treatment and its impact on quality of life: a multicenter cross-sectional study in a low- and middle-income country.
BMC Cancer. 2025;25:975.
PubMed Abstract available

AL-MATRAFI AR, Bedair KF, Srinivasan S, Palmer C, et al
Clinical and pharmacogenomic predictors of survival in tamoxifen treated breast cancer female patients: a real-world study.
BMC Cancer. 2025;25:974.
PubMed Abstract available

May 2025

WANG C, Chen J, Lv X, Yun T, et al
Ki-67-Playing a key role in breast cancer but difficult to apply precisely in the real world.
BMC Cancer. 2025;25:962.
PubMed Abstract available

YANG B, Sun Z, Ouyang Q, Tong Z, et al
Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China.
BMC Cancer. 2025;25:951.
PubMed Abstract available

SCHANTZ C, Gnangnon FHR, Aboubakar M, Agbodande AK, et al
Barriers and opportunities related to access to oncology care in Benin: a qualitative study on breast cancer.
BMC Cancer. 2025;25:947.
PubMed Abstract available

NOPOUR R
Prediction of one-year recurrence among breast cancer patients undergone surgery using artificial intelligence-based algorithms: a retrospective study on prognostic factors.
BMC Cancer. 2025;25:940.
PubMed Abstract available

HE C, Yu T, Yang L, He L, et al
Clinical prediction of pathological complete response in breast cancer: a machine learning study.
BMC Cancer. 2025;25:933.
PubMed Abstract available

RAJABPOUR MV, Seyyedsalehi MS, Nahvijou A, Nemati S, et al
Evaluating the breast cancer quality of care indicators in Iran; multicenter study.
BMC Cancer. 2025;25:925.
PubMed Abstract available

ARPINO G, De Angelis C, Gerratana L, Lambertini M, et al
Patient preferences for treatments in hormone receptor-positive/HER2-negative metastatic breast cancer in Italy: a discrete choice experiment study.
BMC Cancer. 2025;25:920.
PubMed Abstract available

NDLOVU AK, Kasvosve I, Rantshabeng PS, Sharma K, et al
Female breast cancer classification using immunohistochemistry biomarkers staining in Botswana.
BMC Cancer. 2025;25:893.
PubMed Abstract available

LI H, Zhang CT, Shao HG, Pan L, et al
Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features.
BMC Cancer. 2025;25:886.
PubMed Abstract available

MOVAHED F, Dehbozorgi M, Goodarzi S, Abianeh FE, et al
Effect of breast cancer surgery on levels of depression and anxiety: a systematic review and meta-analysis.
BMC Cancer. 2025;25:889.
PubMed Abstract available

LU Y, Shi Z, Zhao Q, Bi Z, et al
Exploring the clinical value of regional nodal irradiation in sentinel lymph node positive breast cancer patients omitting axillary dissection.
BMC Cancer. 2025;25:866.
PubMed Abstract available

ZARGARANI N, Kavousi M, Aliasgari E
A potential new strategy for BC treatment: NPs containing solanine and evaluation of its anticancer and antimetastatic properties.
BMC Cancer. 2025;25:860.
PubMed Abstract available

BROWN C, Kang HA, Johnsrud M, Terry J, et al
Assessing equity of care across metastatic breast cancer treatment junctures: a multi-site retrospective cohort study.
BMC Cancer. 2025;25:861.
PubMed Abstract available

KANG Y, Han B, Kong Y, Liu S, et al
Efficacy and safety of first-line CDK4/6 inhibitors plus AI therapy for patients with HR +/HER2- advanced breast cancer: a network meta-analysis.
BMC Cancer. 2025;25:843.
PubMed Abstract available

DE SOUZA MAMEDE VF, Bernabe RAM, Santos TG, da Silva LL, et al
Risk of sarcopenia in women with breast cancer: a comparative analysis of screening tools.
BMC Cancer. 2025;25:839.
PubMed Abstract available

AHMAD S, Zafar I, Shafiq S, Sehar L, et al
Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis.
BMC Cancer. 2025;25:830.
PubMed Abstract available

YANG Y, Liao T, Lin XH, Ouyang R, et al
Dual-region MRI radiomic analysis indicates increased risk in high-risk breast lesions: bridging intratumoral and peritumoral radiomics for precision decision-making.
BMC Cancer. 2025;25:828.
PubMed Abstract available

YILDIRIM S, Basoglu T, Dogan A, Akdag G, et al
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
BMC Cancer. 2025;25:833.
PubMed Abstract available

April 2025

KHAN K, Anwar M, Badshah Y, Ashraf NM, et al
Zapotin mitigates breast cancer progression by targeting PKCepsilon mediated glycolytic pathway regulation.
BMC Cancer. 2025;25:798.
PubMed Abstract available

HOLM JB, Bruun JM, Christiansen P, Thomsen RW, et al
HbA(1c) levels and breast cancer prognosis in women without diabetes.
BMC Cancer. 2025;25:790.
PubMed Abstract available

ZHANG L, Li S, Shi J, Guo H, et al
The LncRNA RMST-miR-4295-ITPR1 axis: a key mechanism in regulating autophagy in triple-negative breast cancer cells.
BMC Cancer. 2025;25:782.
PubMed Abstract available

LI Z, Zhao Z, Zhang T, Yang X, et al
Association between triglyceride-glucose related indicators, genetic risk, and incident breast cancer among postmenopausal women in UK Biobank.
BMC Cancer. 2025;25:781.
PubMed Abstract available

ESMAELI M, Dehabadi MD, Khaleghi AA
Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature.
BMC Cancer. 2025;25:772.
PubMed Abstract available

RAVEENDRAN C, Meloot SS, Yadev IP
Clinical and biochemical amenorrhea in premenopausal patients with breast cancer treated with chemotherapy - a prospective cohort study.
BMC Cancer. 2025;25:753.
PubMed Abstract available

GLORY A, Patocskai E, Wong P
Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients.
BMC Cancer. 2025;25:748.
PubMed Abstract available

ZHANG Y, Wang H, Wang Y, Ma B, et al
FOXO1 mediates miR-99a-5p/E2F7 to restrain breast cancer cell proliferation and induce apoptosis.
BMC Cancer. 2025;25:747.
PubMed Abstract available

GUPTA H, Raghubansi A, Bharat, Sharma K, et al
Targeting GSK3beta and signaling pathways in breast cancer: role of individual members of miR- 23/24/27 cluster.
BMC Cancer. 2025;25:737.
PubMed Abstract available

CASTELLANO I, Rousset S, Casella D, Capella G, et al
Early detection of triple-negative breast cancer: evidence of a favourable prognostic impact in a comparative analysis of screen-detected versus symptomatic cases.
BMC Cancer. 2025;25:730.
PubMed Abstract available

LIAN W, Li L, Chen D, Hong C, et al
Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a multi-center retrospective study.
BMC Cancer. 2025;25:723.
PubMed Abstract available

LIU J, Guan X, Gao S, Quan L, et al
Novel insight of critical genes involved in breast cancer brain metastasis: evidence from a cross-tissue transcriptome association study and validation through external clinical cohorts.
BMC Cancer. 2025;25:707.
PubMed Abstract available

RASHID FA, Anwar W, Kandakurti PK, Al Qawasmeh KHA, et al
Physical rehabilitation program for cardiorespiratory health and quality of life among breast cancer survivors in UAE: a randomized control trial.
BMC Cancer. 2025;25:705.
PubMed Abstract available

SAGDIC MF, Dincer B, Ozaslan C
De-escalation of axillary surgery in early breast cancer: translating ACOSOG Z0011 study into clinical practice for breast-conserving surgery patients with positive sentinel lymph node biopsy.
BMC Cancer. 2025;25:706.
PubMed Abstract available

TANG H, Zhang W, Li X, Zou Q, et al
Impact of early multidisciplinary team interventions on dietary management behavior in breast cancer patients: a pilot randomized controlled trial.
BMC Cancer. 2025;25:699.
PubMed Abstract available

LI Z, Miao H, Bao W, Zhang L, et al
Development and validation of a nomogram model of lung metastasis in breast cancer based on machine learning algorithm and cytokines.
BMC Cancer. 2025;25:692.
PubMed Abstract available

LIN X, Yang H, Cai T, Yang Z, et al
Polygonum multiflorum Stilbene Glycoside Oligomers induce the ferroptosis of triple negative breast cancer cells.
BMC Cancer. 2025;25:676.
PubMed Abstract available

ROUX A, Hervouet L, Di Stefano F, French DP, et al
Correction: Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.
BMC Cancer. 2025;25:687.
PubMed

GETU MA, Kaba M, Addissie A, Seife E, et al
Patients' experiences of cognitive behavioural therapy integrated with activity pacing: a qualitative study.
BMC Cancer. 2025;25:670.
PubMed Abstract available

REN W, Yu Y, Wang T, Wang X, et al
Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer.
BMC Cancer. 2025;25:668.
PubMed Abstract available

BOSSON-AMEDENU S, Ayitey E, Ayiah-Mensah F, Asare L, et al
Evaluating key predictors of breast cancer through survival: a comparison of AFT frailty models with LASSO, ridge, and elastic net regularization.
BMC Cancer. 2025;25:665.
PubMed Abstract available

ZHU W, Fang J, Zhang Y, Chen M, et al
Validation of in vivo dose using EPID combined with fan-beam CT guidance in post-breast-conserving radiotherapy for early-stage breast cancer.
BMC Cancer. 2025;25:667.
PubMed Abstract available

AKHLAQI M, Ghofrani A, Najdi N, Ranjkesh M, et al
A systematic review and meta-analysis of pregnancy-associated breast cancer incidence rate.
BMC Cancer. 2025;25:660.
PubMed Abstract available

TARAPARA B, Shah F
Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer.
BMC Cancer. 2025;25:650.
PubMed Abstract available

WANG S, Guo J, Xian X, Li M, et al
Correction: Distinct 5-methylcytosine profiles of LncRNA in breast cancer brain metastasis.
BMC Cancer. 2025;25:625.
PubMed

WANG G, Wang S, Song W, Lu C, et al
Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer.
BMC Cancer. 2025;25:623.
PubMed Abstract available

ANDO Y, Miyadera H, Bando H, Hashimoto S, et al
HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer.
BMC Cancer. 2025;25:610.
PubMed Abstract available

CARVALHO MM, Bah A, Azrib S, Hiatt RA, et al
Evaluation of performance indicators of a national breast cancer screening program in Casablanca, Morocco.
BMC Cancer. 2025;25:612.
PubMed Abstract available

WU Z, Zhang R, Wu X, Meng X, et al
Causal association of breast cancer with immune cells: new evidence from bi-directional Mendelian randomization using GWAS summary statistics.
BMC Cancer. 2025;25:609.
PubMed Abstract available

NIU R, Wang C, Xie Y, Li S, et al
Prognostic significance of CD8 + tumor-infiltrating lymphocytes in operable breast cancer: a meta-analysis.
BMC Cancer. 2025;25:601.
PubMed Abstract available

SUN Y, Liao Q, Fan Y, Cui C, et al
DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT.
BMC Cancer. 2025;25:589.
PubMed Abstract available

March 2025

AN T, Han H, Xie J, Wang Y, et al
Enhancing prediction and stratifying risk: machine learning and bayesian-learning models for catheter-related thrombosis in chemotherapy patients.
BMC Cancer. 2025;25:552.
PubMed Abstract available

WANG S, Guo J, Xian X, Li M, et al
Distinct 5-methylcytosine profiles of LncRNA in breast cancer brain metastasis.
BMC Cancer. 2025;25:557.
PubMed Abstract available

HANNEMANN J, Oliveira-Ferrer L, Goele AK, Mileva Y, et al
L-arginine dependence of breast cancer - molecular subtypes matter.
BMC Cancer. 2025;25:546.
PubMed Abstract available

CHERAGHALIZADEH H, Adib-Rad H, Pasha H, Chehrazi M, et al
Effectiveness of face to face and virtual education to promote breast self-examination based on the theory of planned behavior: a randomized controlled trial study.
BMC Cancer. 2025;25:548.
PubMed Abstract available

TIAN H, Cai L, Gui Y, Cai Z, et al
Two-stage augmentation for detecting malignancy of BI-RADS 3 lesions in early breast cancer.
BMC Cancer. 2025;25:537.
PubMed Abstract available

YEAN AW, Leong E, King OS, Mohamad Z, et al
Breast cancer treatment modalities, treatment delays, and survival in Brunei Darussalam.
BMC Cancer. 2025;25:510.
PubMed Abstract available

MARBACH D, Brouer-Visser J, Brennan L, Wilson S, et al
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor).
BMC Cancer. 2025;25:500.
PubMed Abstract available

BERTOZZI S, Londero AP, Diaz Nanez JA, Di Vora R, et al
Breast cancer care for the aging population: a focus on age-related disparities in breast cancer treatment.
BMC Cancer. 2025;25:492.
PubMed Abstract available

ROUX A, Hervouet L, Stefano FD, French DP, et al
Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.
BMC Cancer. 2025;25:483.
PubMed Abstract available

ZHANG N, Shao X, Xu L, Zhu W, et al
Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion imaging mri for triple-negative breast cancer: a comparison with molecular subtypes and histological grades.
BMC Cancer. 2025;25:465.
PubMed Abstract available

QIAN L, Cairong Z, Yongdong L, Quan L, et al
Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer.
BMC Cancer. 2025;25:453.
PubMed Abstract available

TERREL-POCCOMO MK, Santillan-Romero G, Quispe-Vicuna C, Ybaseta-Medina J, et al
Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027.
BMC Cancer. 2025;25:463.
PubMed Abstract available

BOUZID RS, Bouzid R, Labed H, Serhani I, et al
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers.
BMC Cancer. 2025;25:454.
PubMed Abstract available

YARMAND S, Atashi N, Kazemi I, Mahmoudi-Zadeh M, et al
Correction: Association of portfolio diet score with breast cancer risk: insights from a case-control analysis.
BMC Cancer. 2025;25:448.
PubMed

RAVINDRANATH KJ, Srinivasan H
Deciphering the anti-neoplastic potential of Allium ascalonicum in averting the proliferation and epithelial-mesenchymal transition of triple-negative breast cancer through virtual docking and In Vitro approaches.
BMC Cancer. 2025;25:414.
PubMed Abstract available

LIU X, Meng Q, Fan W, Ning L, et al
The effects of intermittent fasting on anthropometric indices, glycemic profile, chemotherapy-related toxicity, and subjective perception in gynecological and breast cancer patients: a systematic review and meta-analysis.
BMC Cancer. 2025;25:419.
PubMed Abstract available

XUE C, Yang W, Hu A, He C, et al
CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer.
BMC Cancer. 2025;25:410.
PubMed Abstract available

MASELLI-SCHOUERI JH, De Carvalho LEW, De Melo Sette CV, de Abreu LC, et al
How are we allocating physicians to deal with breast cancer in men and women in Brazil?
BMC Cancer. 2025;25:392.
PubMed Abstract available

KANWAL W, Narjis K, Musani S, Nancy F, et al
Exploring Zanidatamab's efficacy across HER2-positive Malignancies: a narrative review.
BMC Cancer. 2025;25:382.
PubMed Abstract available

February 2025

ZHANG K, Shen J, Liang Y, Meng X, et al
Reduction of subclinical acute cardiac injury through DIBH radiotherapy: a single-institution real-world clinical cohort analysis.
BMC Cancer. 2025;25:373.
PubMed Abstract available

EGELBERG M, De Marchi T, Schultz N, Tran L, et al
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.
BMC Cancer. 2025;25:374.
PubMed Abstract available

YAN M, Zong Z, Guo W, Li X, et al
PIK3CA gene mutation status associated with poor prognosis of breast cancer: a retrospective cohort study.
BMC Cancer. 2025;25:365.
PubMed Abstract available

HAYES BL, Fleming L, Mahmoud O, Martin RM, et al
The impact of sleep on breast cancer-specific mortality: a Mendelian randomisation study.
BMC Cancer. 2025;25:357.
PubMed Abstract available

WONGMANEERUNG P, Chitapanarux I, Traisathit P, Prasitwattanaseree S, et al
The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand.
BMC Cancer. 2025;25:346.
PubMed Abstract available

LI Y, Song W, Gao P, Guan X, et al
Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021.
BMC Cancer. 2025;25:330.
PubMed Abstract available

RANTALA J, Seppa K, Eriksson J, Heinavaara S, et al
Incidence trends of early-onset breast cancer by lifestyle risk factors.
BMC Cancer. 2025;25:326.
PubMed Abstract available

XIE L, Kong X, Lin D, Song J, et al
Application of chest wall perforator flaps in oncoplastic breast-conserving surgery.
BMC Cancer. 2025;25:328.
PubMed Abstract available

HATLETVEDT ND, Engebrethsen C, Geisler J, Geisler S, et al
The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy.
BMC Cancer. 2025;25:308.
PubMed Abstract available

WENWEN, Jiang Z, Liu J, Liu D, et al
Integrating ultrasound radiomics and clinicopathological features for machine learning-based survival prediction in patients with nonmetastatic triple-negative breast cancer.
BMC Cancer. 2025;25:291.
PubMed Abstract available

WU X, Yuan F, Guo L, Gao D, et al
Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment.
BMC Cancer. 2025;25:285.
PubMed Abstract available

YARMAND S, Atashi N, Kazemi I, Mahmoudi-Zadeh M, et al
Association of portfolio diet score with breast cancer risk: insights from a case-control analysis.
BMC Cancer. 2025;25:274.
PubMed Abstract available

ZENG Q, Deng Y, Nan J, Zou Z, et al
Delta dual?region DCE-MRI radiomics from breast masses predicts axillary lymph node response after neoadjuvant therapy for breast cancer.
BMC Cancer. 2025;25:264.
PubMed Abstract available

XIE H, Tan T, Li Q, Li T, et al
Revolutionizing HER-2 assessment: multidimensional radiomics in breast cancer diagnosis.
BMC Cancer. 2025;25:265.
PubMed Abstract available

ZANGOURI V, Balaneji SS, Golmoradi R, Kafili E, et al
Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer.
BMC Cancer. 2025;25:257.
PubMed Abstract available

FAMILI-YOUTH EHH, Famili-Youth A, Yang D, Siddique A, et al
Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis.
BMC Cancer. 2025;25:247.
PubMed Abstract available

ZHANG J, Wang Y, Liu Y, Chen H, et al
Proteomic profiling reveals biological processes and biomarkers involved in the pathogenesis of occult breast cancer.
BMC Cancer. 2025;25:231.
PubMed Abstract available

JIAO D, Chen X, Sun X, Lu Z, et al
A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer.
BMC Cancer. 2025;25:209.
PubMed Abstract available

YAMADA M, Chishima T, Ishikawa T, Narui K, et al
Breast cancer risk assessment based on a predictive model: evaluation of risk factors among Japanese women.
BMC Cancer. 2025;25:206.
PubMed Abstract available

SHEIKHNEZHAD L, Hassankhani H, Sawin EM, Sanaat Z, et al
What does intimate partner violence mean for women with breast cancer? Experiences of Iranian women.
BMC Cancer. 2025;25:190.
PubMed Abstract available

January 2025

GETIE M, Mekonnen BA, Seifu D, Mulugeta Y, et al
Serum cardiac and inflammatory biomarker levels following chemotherapy among female patients with breast cancer attending at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
BMC Cancer. 2025;25:175.
PubMed Abstract available

GODIVEAU M, Passildas J, Thivat E, Casile M, et al
Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial.
BMC Cancer. 2025;25:174.
PubMed Abstract available

KAUTZ-FREIMUTH S, Shukri A, Stracke C, Isselhard A, et al
Factors influencing role preferences in decision-making of healthy women with BRCA1/2 pathogenic variants: subanalysis from a randomised controlled decision coaching trial.
BMC Cancer. 2025;25:164.
PubMed Abstract available

WANG Y, Wang R, Lu D, Zeng Y, et al
Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients.
BMC Cancer. 2025;25:156.
PubMed Abstract available

BHANGDIA K, Natarajan A, Rudolfson N, Verguet S, et al
The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facility.
BMC Cancer. 2025;25:146.
PubMed Abstract available

PETE R, Pinard C, Sirodot F, Molnar I, et al
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial.
BMC Cancer. 2025;25:123.
PubMed Abstract available

JEONG SH, Chun SM, Kim M, Lee YS, et al
Multimodal treatments and the risk of breast cancer-related lymphedema: insights from a nationally representative cohort in South Korea.
BMC Cancer. 2025;25:114.
PubMed Abstract available

NIU S, Sun T, Wang M, Yao L, et al
Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis.
BMC Cancer. 2025;25:115.
PubMed Abstract available

BRANDSTETTER LS, Grau A, Heuschmann PU, Muller-Reiter M, et al
Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study.
BMC Cancer. 2025;25:125.
PubMed Abstract available

SAFIEDDINE B, Geyer S, Sperlich S, Beller J, et al
Factors associated with health-related quality of life in women with paid work at breast cancer diagnosis: a German repeated cross-sectional study over the first five years after primary surgery.
BMC Cancer. 2025;25:98.
PubMed Abstract available

BECK MH, Brachaczek IA, Gebert P, Blohmer JU, et al
Incidence of seroma and postoperative complications after breast surgery before and during the Covid-19 pandemic: results from a retrospective multicenter analysis.
BMC Cancer. 2025;25:91.
PubMed Abstract available

LIU M, Kilbreath S, Yee J, Beith J, et al
Motivations and perceptions for physical activity in women living with metastatic breast cancer: a qualitative interview study.
BMC Cancer. 2025;25:80.
PubMed Abstract available

BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al
Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
BMC Cancer. 2025;25:72.
PubMed Abstract available

CUMMINGS-JOHN C, Bah AJ, Smalle IO, Challe CC, et al
The patterns of presentation, management and outcomes of breast cancer patients at a tertiary health facility in Sierra Leone.
BMC Cancer. 2025;25:70.
PubMed Abstract available

FENG Y, Song Q, Yan L, Li R, et al
Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups.
BMC Cancer. 2025;25:68.
PubMed Abstract available

ZHANG F, Wang S, Liu B, Yang W, et al
Role of immediate injection of methylene blue after fiberoptic ductoscopy in selective ductectomy for patients with pathological nipple discharge.
BMC Cancer. 2025;25:60.
PubMed Abstract available

LIU M, Kilbreath S, Yee J, Beith J, et al
Personal and behavioural factors that influence physical activity in women living with metastatic breast cancer: a qualitative interview study.
BMC Cancer. 2025;25:48.
PubMed Abstract available

CHE J, Chen B, Wang X, Liu B, et al
Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer.
BMC Cancer. 2025;25:35.
PubMed Abstract available

XU L, Li P, Hu Y, Xing W, et al
Cross-cultural adaptation of the simple Chinese version of the medication adherence reasons scale in patients undergoing adjuvant endocrine therapy for breast cancer.
BMC Cancer. 2025;25:41.
PubMed Abstract available

WANG Z, Bi Z, Bo H, Xu J, et al
PRAF2 as a novel biomarker for breast cancer with machine learning and experimentation validation.
BMC Cancer. 2025;25:32.
PubMed Abstract available

TANG J, Guo B, Zhong C, Chi J, et al
Detection of differences in physical symptoms between depressed and undepressed patients with breast cancer: a study using K-medoids clustering.
BMC Cancer. 2025;25:23.
PubMed Abstract available

VAYNRUB A, Salazar B, Feng YE, West H, et al
The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.
BMC Cancer. 2025;25:19.
PubMed Abstract available

DA SILVA JL, Thuler LCS, de Melo AC
Breast cancer patterns by age groups in Brazil: insights from population-based registries data.
BMC Cancer. 2025;25:18.
PubMed Abstract available

NTEKIM A, Folasire A, Odukoya OA, Sowunmi A, et al
Pathway to care among adolescents and young adults with breast cancer in Nigeria: a mixed methods study.
BMC Cancer. 2025;25:11.
PubMed Abstract available

LONG Z, Qiu Y, Long Z, Jin Z, et al
Epidemiology of breast cancer in Chinese women from 1990 to 2021: a systematic analysis and comparison with the global burden.
BMC Cancer. 2025;25:3.
PubMed Abstract available

LIU J, Zhang J, Li H, Song G, et al
Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study.
BMC Cancer. 2025;25:9.
PubMed Abstract available

December 2024

GLYNOU SP, Sousi S, Cook H, Zargaran A, et al
A comparison of acellular dermal matrices (ADM) efficacy and complication profile in women undergoing implant-based breast reconstruction: a systematic review and network meta-analysis.
BMC Cancer. 2024;24:1598.
PubMed Abstract available

KAHRAMAN S, Hizal M, Demirel BC, Guven DC, et al
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.
BMC Cancer. 2024;24:1592.
PubMed Abstract available

LEE J, Kang B, Jung JH, Kim HJ, et al
Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark) for targeting suspicious axillary lymph nodes in patients with breast cancer.
BMC Cancer. 2024;24:1588.
PubMed Abstract available

ZHANG F, Wang S, Yu C, Jin W, et al
The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy.
BMC Cancer. 2024;24:1585.
PubMed Abstract available

LIU J, Sun Y, Qi P, Wo Y, et al
Gene expression profiling for the diagnosis of male breast cancer.
BMC Cancer. 2024;24:1584.
PubMed Abstract available

CHEN Y, He J, Song T, Zhang Y, et al
Comparing supraclavicular surgery with radiotherapy versus radiotherapy alone in breast cancer patients with ipsilateral supraclavicular lymph node metastasis: a two-center retrospective cohort study.
BMC Cancer. 2024;24:1572.
PubMed Abstract available

KIRLI BOLUKBAS M, Figen M, Kocak Uzel E
Cancer awareness across borders: a comparative study of internet search trends for breast and prostate cancer in Europe and Turkey.
BMC Cancer. 2024;24:1563.
PubMed Abstract available

SUN H, Liang J, Xue S, Zhang X, et al
Establishment and clinical application of a prognostic index for inflammatory status in triple-negative breast cancer patients undergoing neoadjuvant therapy using machine learning.
BMC Cancer. 2024;24:1559.
PubMed Abstract available

SCHMIDT M, Vernooij R, van Nuland M, Smeijsters E, et al
Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival.
BMC Cancer. 2024;24:1553.
PubMed Abstract available

AZIZ M, Ejaz SA, Channar PA, Alkhathami AG, et al
Identification of dimethyl 2,2'-((methylenebis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)-6,1phenylene))bis(oxy))diacetate (TAJ4) as antagonist of NEK-Family: a future for potential drug discovery.
BMC Cancer. 2024;24:1521.
PubMed Abstract available

ZHANG X, Zhang Y, Du W
Alleviating role of ketamine in breast cancer cell-induced osteoclastogenesis and tumor bone metastasis-induced bone cancer pain through an SRC/EGR1/CST6 axis.
BMC Cancer. 2024;24:1535.
PubMed Abstract available

GNANGNON FHR, Lawani I, Knight SR, Parente A, et al
Assessing the continuum of care in Sub-Saharan African hospitals performing surgery for breast cancer: a secondary analysis of the GlobalSurg 3 study.
BMC Cancer. 2024;24:1529.
PubMed Abstract available

WANG Y, Zhong P, Wang C, Huang W, et al
Genetic overlap between breast cancer and sarcopenia: exploring the prognostic implications of SLC38A1 gene expression.
BMC Cancer. 2024;24:1533.
PubMed Abstract available

EKHOLM A, Wang Y, Vallon-Christersson J, Boissin C, et al
Prediction of gene expression-based breast cancer proliferation scores from histopathology whole slide images using deep learning.
BMC Cancer. 2024;24:1510.
PubMed Abstract available

NOMAN S, Elarusy NME, Rahman HA, Ismail S, et al
Investigating the effect of the educational intervention based on the Health Belief Model on the knowledge and beliefs of Yemeni teachers in the use of breast cancer screening: a randomized controlled trial study.
BMC Cancer. 2024;24:1506.
PubMed Abstract available

BOAITEY GA, Martini R, Stonaker B, Bonsu EO, et al
Patterns of breast cancer locoregional relapse, metastasis, and subtypes in Ghana.
BMC Cancer. 2024;24:1485.
PubMed Abstract available

November 2024

RONG RY, Shen YK, Wu SN, Xu SH, et al
Prediction model for ocular metastasis of breast cancer: machine learning model development and interpretation study.
BMC Cancer. 2024;24:1472.
PubMed Abstract available

LI Y, Yang X, Ma L
Prognostic prediction for HER2-low breast cancer patients using a novel machine learning model.
BMC Cancer. 2024;24:1474.
PubMed Abstract available

KVERNROD AB, Rasmussen CH, Pedersen LH, Bojesen SE, et al
Attitudes towards risk-stratified breast cancer screening in Denmark - a qualitative study.
BMC Cancer. 2024;24:1453.
PubMed Abstract available

ZHANG H, Jin J, Li L, Wang L, et al
Outcome and toxicities of postmastectomy radiotherapy with integral cervicothoracic thermoplastic mask.
BMC Cancer. 2024;24:1445.
PubMed Abstract available

MO JL, Li X, Lei L, Peng J, et al
A machine learning model revealed that exosome small RNAs may participate in the development of breast cancer through the chemokine signaling pathway.
BMC Cancer. 2024;24:1435.
PubMed Abstract available

MEHNERT E, Moller FS, Hofbauer C, Weidlich A, et al
Palliative care of proximal femur metastatic disease and osteolytic lesions: results following surgical and radiation treatment.
BMC Cancer. 2024;24:1431.
PubMed Abstract available

QIAN C, Xing Y, Cheng W
Causal effect between breast cancer and ovarian cancer: a two-sample mendelian randomization study.
BMC Cancer. 2024;24:1433.
PubMed Abstract available

MALMSTROM M, Holst-Hansson A, Olsson Moller U
The complexity of needs and roles of family members during breast cancer rehabilitation: a qualitative study.
BMC Cancer. 2024;24:1430.
PubMed Abstract available

SHI S, Ma HY, Sang YZ, Ju YB, et al
CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis.
BMC Cancer. 2024;24:1429.
PubMed Abstract available

POWLA PP, Medina H, Villamar D, Huard C, et al
Racial disparities in the frequency and timing of code status orders among women with breast cancer.
BMC Cancer. 2024;24:1426.
PubMed Abstract available

SCHUMACHER TJ, Iyer AV, Rumbley J, Ronayne CT, et al
Exploring the impact of mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 on breast cancer cell metabolism.
BMC Cancer. 2024;24:1415.
PubMed Abstract available

GOTINK J, Rosskamp M, Silversmit G, Verdoodt F, et al
Exploring educational disparities in breast cancer dynamics: a comprehensive analysis of incidence, death within 5 years of diagnosis, and mortality in the Belgian context.
BMC Cancer. 2024;24:1399.
PubMed Abstract available

SRIVASTAVA TP, Ajmeriya S, Goel I, Talukdar J, et al
Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer.
BMC Cancer. 2024;24:1398.
PubMed Abstract available

XU Y, Huang L, Wang J, He J, et al
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinic
BMC Cancer. 2024;24:1387.
PubMed Abstract available

YOON SH, Lee S, Kim HS, Song J, et al
NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-beta/Smad signaling pathway in MCF-7 tumor spheroid.
BMC Cancer. 2024;24:1370.
PubMed Abstract available

BI Z, Cheng WH, Zheng WH, Ren TY, et al
The optimal timing of breast cancer surgery after COVID-19 infection: an observational study.
BMC Cancer. 2024;24:1348.
PubMed Abstract available

October 2024

WANG Z, You P, Yang Z, Xiao H, et al
PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safety.
BMC Cancer. 2024;24:1339.
PubMed Abstract available

KATAOKA N, Hata T, Hosomi K, Hirata A, et al
Predictors of abemaciclib discontinuation in patients with breast cancer: a multicenter retrospective cohort study.
BMC Cancer. 2024;24:1335.
PubMed Abstract available

ONER I, Turkel A, Inci BK, Tolunay PK, et al
Impact of the CPS-EG score as a new prognostic biomarker in triple-negative breast cancer patients who received neoadjuvant chemotherapy.
BMC Cancer. 2024;24:1338.
PubMed Abstract available

GARCIA-HERNANDEZ AP, Corona DN, Carlos-Reyes A, Sierra-Martinez M, et al
The lncRNA AFAP1-AS1 is upregulated in metastatic triple-negative breast tumors and controls hypoxia-activated vasculogenic mimicry and angiogenesis.
BMC Cancer. 2024;24:1332.
PubMed Abstract available

NEVIERE Z, Blanc-Fournier C, Guizard AV, Elie N, et al
Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach.
BMC Cancer. 2024;24:1328.
PubMed Abstract available

JIAO S, Wang Y, Ma J, Shen J, et al
Interobserver variability of clinical target volume delineation in patients undergoing breast-conserving surgery without surgical clips: a pilot study on preoperative magnetic resonance simulation.
BMC Cancer. 2024;24:1321.
PubMed Abstract available

MSAMI K, Nyamle N, Ruwaichi T, Chuwa H, et al
Strengthening uptake of breast cancer screening services in Tanzania; re-visiting the breast cancer screening messages.
BMC Cancer. 2024;24:1312.
PubMed Abstract available

YANG L, Ding H, Gao X, Xu Y, et al
Can we skip invasive biopsy of sentinel lymph nodes? A preliminary investigation to predict sentinel lymph node status using PET/CT-based radiomics.
BMC Cancer. 2024;24:1316.
PubMed Abstract available

SANTOS TG, da Silva LL, Bernabe RAM, Albergaria BH, et al
Anthropometric equation has sufficient diagnostic capacity to identify sarcopenia in women with breast cancer.
BMC Cancer. 2024;24:1310.
PubMed Abstract available

SEN GA, Aydin E, Guliyev M, Oztas NS, et al
The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer.
BMC Cancer. 2024;24:1311.
PubMed Abstract available

HACHACHE R, Yahyaouy A, Riffi J, Tairi H, et al
Advancing personalized oncology: a systematic review on the integration of artificial intelligence in monitoring neoadjuvant treatment for breast cancer patients.
BMC Cancer. 2024;24:1300.
PubMed Abstract available

BATCHELOR S, Lunnay B, Macdonald S, Ward PR, et al
How social class shapes breast cancer risk perspectives and prevention practices of Australian midlife women: a qualitative study using the concept of 'breast cancer candidacy'.
BMC Cancer. 2024;24:1295.
PubMed Abstract available

CUI M, Fu J, Li Q
Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis.
BMC Cancer. 2024;24:1293.
PubMed Abstract available

LIU J, He M, Jiang M, Zhou S, et al
Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study.
BMC Cancer. 2024;24:1290.
PubMed Abstract available

ZIEGLER P, Hartkopf AD, Wallwiener M, Haberle L, et al
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.
BMC Cancer. 2024;24:1284.
PubMed Abstract available

CHEN W, Pang L, Jin X, Chen H, et al
Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial.
BMC Cancer. 2024;24:1276.
PubMed Abstract available

WANG L, Zhen M, Liao L, Li H, et al
Effects of dietary habits and catheterization type on breast cancer-related lymphedema: a retrospective cohort study.
BMC Cancer. 2024;24:1264.
PubMed Abstract available

WANG Y, Xu H, Sa Q, Li L, et al
Development of graded prognostic assessment for breast Cancer brain metastasis incorporating extracranial metastatic features: a retrospective analysis of 284 patients.
BMC Cancer. 2024;24:1262.
PubMed Abstract available

ZHAO Y, He M, Cui L, Zhang M, et al
Systematic screening of protein-coding gene expression identified VWF as a potential key regulator in anthracycline-based chemotherapy-exacerbated metastasis of breast cancer.
BMC Cancer. 2024;24:1243.
PubMed Abstract available

LI Z, Jian C, Li Y, Pan Z, et al
Clinical benefits of deep inspiration breath-hold in postoperative radiotherapy for right-sided breast cancer: a meta-analysis.
BMC Cancer. 2024;24:1238.
PubMed Abstract available

REN K, Wang S, Ye T, Zhu Z, et al
Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC).
BMC Cancer. 2024;24:1237.
PubMed Abstract available

NOURI M, Mansouri F, Jafari F, Ranjbar Zahedani M, et al
Association between processed and ultra-processed food intake and the risk of breast cancer: a case-control study.
BMC Cancer. 2024;24:1234.
PubMed Abstract available

DO TM, Nguyen QHN, Le NHD, Nguyen HD, et al
Association between dietary factors and breast cancer risk: a matched case-control study in Vietnam.
BMC Cancer. 2024;24:1224.
PubMed Abstract available

MA H, Shi L, Zheng J, Zeng L, et al
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancer.
BMC Cancer. 2024;24:1222.
PubMed Abstract available

September 2024

BAHARUN NB, Adam A, Zailani MAH, Rajpoot NM, et al
Automated scoring methods for quantitative interpretation of Tumour infiltrating lymphocytes (TILs) in breast cancer: a systematic review.
BMC Cancer. 2024;24:1202.
PubMed Abstract available

XIONG Z, Liu K, Liu S, Feng J, et al
Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer.
BMC Cancer. 2024;24:1204.
PubMed Abstract available

WANG D, Xie D, Meng S, Mi J, et al
Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses.
BMC Cancer. 2024;24:1217.
PubMed Abstract available

NI M, Zhou L, Lu Y, Guo D, et al
Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort study.
BMC Cancer. 2024;24:1214.
PubMed Abstract available

RAN R, Zhao S, Zhou Y, Hang X, et al
Clinicopathological characteristics, treatment patterns and outcomes in patients with HER2-positive breast cancer based on hormone receptor status: a retrospective study.
BMC Cancer. 2024;24:1216.
PubMed Abstract available

REZAIE-CHAMANI S, Lamyian M, Ahmadi F, Montazeri A, et al
I trust doctors and midwives: exploring breast cancer literacy among women referring to the health centers in Iran.
BMC Cancer. 2024;24:1201.
PubMed Abstract available

OGUNMODEDE EO, Ajala DE, Aluko JO, Anokwuru RA, et al
Promoting breast health among female adolescents: a comparative analysis of the effects of two didactic tools on knowledge and practice regarding breast self-examination in Southwest Nigeria.
BMC Cancer. 2024;24:1183.
PubMed Abstract available

COOK HI, Glynou SP, Sousi S, Zargaran D, et al
Does the use of Acellular Dermal Matrices (ADM) in women undergoing pre-pectoral implant-based breast reconstruction increase operative success versus non-use of ADM in the same setting? A systematic review.
BMC Cancer. 2024;24:1186.
PubMed Abstract available

HU S, Tey SK, Kwong A
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1181.
PubMed Abstract available

WU F, Li N, Wu X, Chen M, et al
EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells.
BMC Cancer. 2024;24:1166.
PubMed Abstract available

TANG M, Rong Y, Li X, Pan H, et al
Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
BMC Cancer. 2024;24:1163.
PubMed Abstract available

KOBAYASHI T, Nishimura M, Hosonaga M, Kizawa R, et al
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancer.
BMC Cancer. 2024;24:1156.
PubMed Abstract available

CHENG Z, Xu H, Wang X, Teng T, et al
A causal relationship between bone mineral density and breast cancer risk: a mendelian randomization study based on east Asian population.
BMC Cancer. 2024;24:1148.
PubMed Abstract available

ZHANG Q, Wang Z, Yao W, Wang S, et al
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer.
BMC Cancer. 2024;24:1143.
PubMed Abstract available

CANCILLA MA, Nemati D, Halsey D, Shah N, et al
Exercise as part of survivorship care in metastatic breast cancer: protocol for the randomized EMBody trial.
BMC Cancer. 2024;24:1137.
PubMed Abstract available

YU X, Yu Y, Huang X, Jiang Z, et al
Unraveling the causal links and novel molecular classification of Crohn's disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling.
BMC Cancer. 2024;24:1134.
PubMed Abstract available

BALLE JK, Vetter M, Kenea TW, Eber-Schulz P, et al
PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study.
BMC Cancer. 2024;24:1127.
PubMed Abstract available

DESWAL B, Bagchi U, Santra MK, Garg M, et al
Inhibition of STAT3 by 2-Methoxyestradiol suppresses M2 polarization and protumoral functions of macrophages in breast cancer.
BMC Cancer. 2024;24:1129.
PubMed Abstract available

LI H, Xu Y, Xu R, Du W, et al
The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle.
BMC Cancer. 2024;24:1122.
PubMed Abstract available

KELLEY-JONES C, Scott SE, Waller J
Acceptability of de-intensified screening for women at low risk of breast cancer: a randomised online experimental survey.
BMC Cancer. 2024;24:1111.
PubMed Abstract available

FASSIER JB, Guittard L, Fervers B, Rouat S, et al
Using intervention mapping to facilitate and sustain return-to work after breast cancer: protocol for the FASTRACS multicentre randomized controlled trial.
BMC Cancer. 2024;24:1107.
PubMed Abstract available

DANDENA FG, Teklewold BT, Darebo TD, Suga YD, et al
Epidemiology and clinical characteristics of breast cancer in Ethiopia: a systematic review.
BMC Cancer. 2024;24:1102.
PubMed Abstract available

XIE X, Fang Y, He L, Chen Z, et al
Individualized prediction of non-sentinel lymph node metastasis in Chinese breast cancer patients with >/= 3 positive sentinel lymph nodes based on machine-learning algorithms.
BMC Cancer. 2024;24:1090.
PubMed Abstract available

August 2024

LIN TE, Wong AW, Cheong DC, Kuo WL, et al
Strategically shifting paradigms: the new era of DIEP flaps with minimally invasive mastectomy: a retrospective cross-sectional study.
BMC Cancer. 2024;24:1072.
PubMed Abstract available

SONG MY, Zhao L, Huang WJ, Cui MM, et al
Preoperative platelet distribution width predicts bone metastasis in patients with breast cancer.
BMC Cancer. 2024;24:1066.
PubMed Abstract available

TANG W, Gao Y, Hong S, Wang S, et al
GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation.
BMC Cancer. 2024;24:1071.
PubMed Abstract available

WANG L, Hong R, Shi S, Wang S, et al
The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer.
BMC Cancer. 2024;24:1067.
PubMed Abstract available

GAO X, Pan T, Gao Y, Zhu W, et al
Acetylation of PGK1 at lysine 323 promotes glycolysis, cell proliferation, and metastasis in luminal A breast cancer cells.
BMC Cancer. 2024;24:1054.
PubMed Abstract available

ZHANG J, Sun H, Gao S, Kang Y, et al
Prediction of disease-free survival using strain elastography and diffuse optical tomography in patients with T1 breast cancer: a 10-year follow-up study.
BMC Cancer. 2024;24:1057.
PubMed Abstract available

LUO C, Yu K, Luo X, Lian T, et al
CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis.
BMC Cancer. 2024;24:1031.
PubMed Abstract available

CHEN JH, Addanki S, Roy D, Bassett R, et al
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA.
BMC Cancer. 2024;24:1016.
PubMed Abstract available

BEKELE K, Nugusu F, Beressa G, Hollis T, et al
Proportion of early-stage breast cancer at diagnosis in Ethiopia: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1017.
PubMed Abstract available

DAJSAKDIPON T, Susiriwatananont T, Wongkraisri C, Ithimakin S, et al
Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand.
BMC Cancer. 2024;24:1018.
PubMed Abstract available

HU L, Gu Y, Xu W, Wang C, et al
Association of clinicopathologic and sonographic features with stromal tumor-infiltrating lymphocytes in triple-negative breast cancer.
BMC Cancer. 2024;24:997.
PubMed Abstract available

AHMADIRAD H, Norouzzadeh M, Teymoori F, Jahromi MK, et al
The predictive role of the total potassium intake and odds of breast cancer: a case-control study.
BMC Cancer. 2024;24:995.
PubMed Abstract available

KAWAMOTO Y, Yamai T, Ikezawa K, Seiki Y, et al
Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer.
BMC Cancer. 2024;24:1000.
PubMed Abstract available

ELZOHERY YHAM, Radwan AH, Gareer SWY, Mamdouh MM, et al
Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis?
BMC Cancer. 2024;24:992.
PubMed Abstract available

LI K, Chai D, Ren S, Lian X, et al
beta2-microglobulin induced apoptosis of tumor cells via the ERK signaling pathway by directly interacting with HFE in HER2-overexpressing breast cancer.
BMC Cancer. 2024;24:991.
PubMed Abstract available

LIN W, Gu C, Chen Z, Xue S, et al
Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization.
BMC Cancer. 2024;24:970.
PubMed Abstract available

WOJCIK KM, Caswell-Jin JL, Wilson OWA, Schechter C, et al
The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study.
BMC Cancer. 2024;24:975.
PubMed Abstract available

HEMATI M, Rivaz M, Khademian Z
Lymphedema self-management mobile application with nurse support for post breast cancer surgery survivors: description of the design process and prototype evaluation.
BMC Cancer. 2024;24:973.
PubMed Abstract available

LEE TF, Chang CH, Chi CH, Liu YH, et al
Utilizing radiomics and dosiomics with AI for precision prediction of radiation dermatitis in breast cancer patients.
BMC Cancer. 2024;24:965.
PubMed Abstract available

July 2024

WAN LW, Zhang C, Zhang YL, Lin F, et al
Prognostic significance of the novel immunonutritional marker of cholesterol-to-lymphocyte ratio in patients with non-metastatic breast cancer.
BMC Cancer. 2024;24:914.
PubMed Abstract available

HU ZY, Liu B, Xie N, Yang X, et al
The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study.
BMC Cancer. 2024;24:915.
PubMed Abstract available

ANABA EA, Alor SK, Badzi CD, Mbuwir CB, et al
Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.
BMC Cancer. 2024;24:920.
PubMed Abstract available

WANG X, Nie L, Zhu Q, Zuo Z, et al
Artificial intelligence assisted ultrasound for the non-invasive prediction of axillary lymph node metastasis in breast cancer.
BMC Cancer. 2024;24:910.
PubMed Abstract available

RAEI M, Heydari K, Tabarestani M, Razavi A, et al
Diagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer: a systematic review and meta-analysis of diagnostic test accuracy.
BMC Cancer. 2024;24:908.
PubMed Abstract available

LI X, Cheng K, Shang MD, Yang Y, et al
MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1.
BMC Cancer. 2024;24:902.
PubMed Abstract available

YIALLOUROU A, Pantavou K, Markozannes G, Pilavas A, et al
Non-genetic factors and breast cancer: an umbrella review of meta-analyses.
BMC Cancer. 2024;24:903.
PubMed Abstract available

JIANG M, Chai Y, Liu J, He M, et al
Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysis.
BMC Cancer. 2024;24:877.
PubMed Abstract available

TANG H, Zhang W, Shen H, Tang H, et al
A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial.
BMC Cancer. 2024;24:859.
PubMed Abstract available

SOHRABEI S, Moghaddasi H, Hosseini A, Ehsanzadeh SJ, et al
Investigating the effects of artificial intelligence on the personalization of breast cancer management: a systematic study.
BMC Cancer. 2024;24:852.
PubMed Abstract available

CHRISTINE D, Christian SF, Ricarda K, Christine K, et al
Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study.
BMC Cancer. 2024;24:856.
PubMed Abstract available

JIA L, Peng J, Sun N, Chen H, et al
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy.
BMC Cancer. 2024;24:850.
PubMed Abstract available

DAMTIE Z, Cherie N, Agidew MM
Breast cancer preventive practices and associated factors among reproductive age women in Wadila District, North East Ethiopia: community based cross-sectional study.
BMC Cancer. 2024;24:843.
PubMed Abstract available

POMEY MP, Iliescu Nelea M, Vialaron C, Normandin L, et al
The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients' point of view.
BMC Cancer. 2024;24:822.
PubMed Abstract available

PIAO YJ, Kim HS, Kim H, Shen J, et al
SerpinB2 deficiency is associated with delayed mammary tumor development and decreased pro-tumorigenic macrophage polarization.
BMC Cancer. 2024;24:792.
PubMed Abstract available

PENG J, Lin Y, Sheng X, Yuan C, et al
Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.
BMC Cancer. 2024;24:789.
PubMed Abstract available

MRABTI H, Sauvaget C, Bendahhou K, Selmouni F, et al
Breast cancer treatment and its impact on survival in Morocco: a study over a decade.
BMC Cancer. 2024;24:786.
PubMed Abstract available

June 2024

OZORIO DUTRA SV, Schwab L, Coury J, Ji M, et al
Process evaluation protocol plan for a home-based physical activity intervention versus educational intervention for persistent taxane-induced peripheral neuropathy (B-HAPI study): a randomized controlled trial.
BMC Cancer. 2024;24:777.
PubMed Abstract available

BOHANSKE MS, Momenzadeh K, van der Zwaal P, Hoogwater FJH, et al
Computed tomography-based structural rigidity analysis can assess tumor- and treatment-induced changes in rat bones with metastatic lesions.
BMC Cancer. 2024;24:767.
PubMed Abstract available

MASHAYEKH-AMIRI S, Jafarabadi MA, Hosseinzadeh M, Kanani ES, et al
Measurement properties of the Iranian version of the breast cancer perception scale (BCPS) according to the COSMIN checklist.
BMC Cancer. 2024;24:743.
PubMed Abstract available

CANINO F, Barbolini M, De Giorgi U, Fontana T, et al
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
BMC Cancer. 2024;24:735.
PubMed Abstract available

JORIS S, Giron P, Olsen C, Seneca S, et al
Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers.
BMC Cancer. 2024;24:723.
PubMed Abstract available

XU C, Sun L, Wang H, Sun J, et al
Identifying the mechanism of polysaccharopeptide against breast cancer based on network pharmacology and experimental verification.
BMC Cancer. 2024;24:726.
PubMed Abstract available

KANG Z, Jin Y, Yu H, Li S, et al
Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:708.
PubMed Abstract available

LI Y, Han D, Shen C
Prediction of the axillary lymph-node metastatic burden of breast cancer by (18)F-FDG PET/CT-based radiomics.
BMC Cancer. 2024;24:704.
PubMed Abstract available

XU JX, Zhu QL, Bi YM, Peng YC, et al
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis.
BMC Cancer. 2024;24:691.
PubMed Abstract available

YE J, Ying J, Chen H, Wu Z, et al
PPIH acts as a potential predictive biomarker for patients with common solid tumors.
BMC Cancer. 2024;24:681.
PubMed Abstract available

May 2024

AZIZ MA, Chowdhury S, Jafrin S, Barek MA, et al
Genetic association of Interleukin-17A polymorphism in Bangladeshi patients with breast and cervical cancer: a case-control study with functional analysis.
BMC Cancer. 2024;24:660.
PubMed Abstract available

YU S, Yue Z, Liu Q
Pectinose induces cell cycle arrest in luminal A and triple-negative breast cancer cells by promoting autophagy through activation of the p38 MAPK signaling pathway.
BMC Cancer. 2024;24:639.
PubMed Abstract available

KUEMMEL S, Harper-Wynne C, Park YH, Franke F, et al
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-po
BMC Cancer. 2024;24:641.
PubMed Abstract available

LAMBERT V, Kane S, Howidi B, Nguyen BN, et al
Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
BMC Cancer. 2024;24:631.
PubMed Abstract available

ZHENG M, Wu L, Xiao R, Cai J, et al
Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation.
BMC Cancer. 2024;24:619.
PubMed Abstract available

WANG Q, Chen H, Yang Q, Qiu J, et al
Awareness and associated factors of venous thromboembolism in breast cancer surgical patients: a cross-sectional study.
BMC Cancer. 2024;24:610.
PubMed Abstract available

EL HABRE R, Aoun R, Tahtouh R, Hilal G, et al
All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.
BMC Cancer. 2024;24:615.
PubMed Abstract available

BOUTRUS RR, Abdelazim YA, Mohammed T, Bayomy M, et al
The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
BMC Cancer. 2024;24:599.
PubMed Abstract available

HAUNER D, Mang A, Donik L, Schederecker F, et al
Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.
BMC Cancer. 2024;24:591.
PubMed Abstract available

SAHU RK, Tandon S, Singh S, Das BC, et al
Methyl CpG binding protein MBD2 has a regulatory role on the BRCA1 gene expression and its modulation by resveratrol in ER+, PR+ & triple-negative breast cancer cells.
BMC Cancer. 2024;24:566.
PubMed Abstract available

SBAITY E, Tamim H, El-Hajj Fuleihan G, Abbas J, et al
Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients with breast cancer: a matched cohort study.
BMC Cancer. 2024;24:560.
PubMed Abstract available

WANG J, Tian C, Zheng BJ, Zhang J, et al
The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
BMC Cancer. 2024;24:549.
PubMed Abstract available

April 2024

HAN JY, Che N, Mo J, Zhang DF, et al
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
BMC Cancer. 2024;24:532.
PubMed Abstract available

ZOU J, Chen Q, He Y, Pan Y, et al
Systematic optimization and evaluation of culture conditions for the construction of circulating tumor cell clusters using breast cancer cell lines.
BMC Cancer. 2024;24:507.
PubMed Abstract available

GILL J, Yendamuri K, Chatterjee U, Yao S, et al
Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
BMC Cancer. 2024;24:461.
PubMed Abstract available

LIU Z, Li J, Zhao F, Ren D, et al
Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.
BMC Cancer. 2024;24:440.
PubMed Abstract available

LI B, Dai S, Wang Q, Jing H, et al
Investigation of correlation between shear wave elastography and lymphangiogenesis in invasive breast cancer and diagnosis of axillary lymph node metastasis.
BMC Cancer. 2024;24:409.
PubMed Abstract available

WU Z, Zhang Q, Jin Y, Zhang X, et al
Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
BMC Cancer. 2024;24:411.
PubMed Abstract available

QIU C, Wang W, Xu S, Li Y, et al
Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
BMC Cancer. 2024;24:402.
PubMed Abstract available

March 2024

ESMAT E, Haidary AM, Saadaat R, Rizvi SN, et al
Association of hormone receptors and human epidermal growth factor receptor-2/neu expressions with clinicopathologic factors of breast carcinoma: a cross-sectional study in a tertiary care hospital, Kabul, Afghanistan.
BMC Cancer. 2024;24:388.
PubMed Abstract available

ZAHEDI H, Alizadeh-Dibazari Z, Mirghafourvand M, Sahebihagh MH, et al
The effectiveness of couple-based interventions on the marital outcomes of women with genital and breast cancer and their partners: a systematic review and meta-analysis.
BMC Cancer. 2024;24:391.
PubMed Abstract available

CHEHELGERDI M, Khorramian-Ghahfarokhi M, Dehkordi FB, Chehelgerdi M, et al
Comment on "A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer".
BMC Cancer. 2024;24:377.
PubMed Abstract available

HUANG W, Wang C, Shen Y, Chen Q, et al
Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.
BMC Cancer. 2024;24:378.
PubMed

REN H, Wang Z, Zhang L, Zhu G, et al
Clinical significance of low expression of CADM3 in breast cancer and preliminary exploration of related mechanisms.
BMC Cancer. 2024;24:367.
PubMed Abstract available

WANG Y, Men X, Gu Y, Wang H, et al
Retraction Note: Haplotype analysis on correlation between transcription factor 7-like 2 gene polymorphism and breast cancer risk.
BMC Cancer. 2024;24:366.
PubMed

CHANDRAN G, Tang N, Ngo ELP, Huang S, et al
Comparing the efficacy of a multi-dimensional breast cancer rehabilitation programme versus a home-based exercise programme during adjuvant cancer treatment.
BMC Cancer. 2024;24:361.
PubMed Abstract available

LOFT LH, Pedersen LH, Bigaard J, Bojesen SE, et al
Attitudes towards risk-stratified breast cancer screening: a population-based survey among 5,001 Danish women.
BMC Cancer. 2024;24:347.
PubMed Abstract available

WANG ZQ, Wu ZX, Wang ZP, Bao JX, et al
Pan-cancer analysis of NUP155 and validation of its role in breast cancer cell proliferation, migration, and apoptosis.
BMC Cancer. 2024;24:353.
PubMed Abstract available

OPUTA CH, Peters E, Otovwe A
Effect of educational intervention on the knowledge, attitude and practice of breast self-examination among female students at a private university in Southern Nigeria.
BMC Cancer. 2024;24:355.
PubMed Abstract available

BOULIFA A, Raftery MJ, Franzen AS, Radecke C, et al
Role of beta-(1-->3)(1-->6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.
BMC Cancer. 2024;24:339.
PubMed Abstract available

KNUDSEN BM, Sondergaard SR, Stacey D, Steffensen KD, et al
Impact of timing and format of patient decision aids for breast cancer patients on their involvement in and preparedness for decision making - the IMPACTT randomised controlled trial protocol.
BMC Cancer. 2024;24:336.
PubMed Abstract available

MAENPAA N, Tiainen L, Hamalainen M, Luukkaala T, et al
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
BMC Cancer. 2024;24:331.
PubMed Abstract available

PALMER S, Blomqvist C, Holmqvist M, Lindman H, et al
Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry.
BMC Cancer. 2024;24:329.
PubMed Abstract available

KANG D, Wang C, Han Z, Zheng L, et al
Exploration of the relationship between tumor-infiltrating lymphocyte score and histological grade in breast cancer.
BMC Cancer. 2024;24:318.
PubMed Abstract available

GOH SP, Ong SC, Chan JE
Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review.
BMC Cancer. 2024;24:316.
PubMed Abstract available

SHITRIT IB, Wang A, Ilan K, Agassi R, et al
Epidemiological, clinical, and pathological characteristics of invasive breast cancer in Bedouin and Jewish women in southern Israel: a retrospective comparative study.
BMC Cancer. 2024;24:310.
PubMed Abstract available

KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
BMC Cancer. 2024;24:308.
PubMed Abstract available

MOLIERE S, Lodi M, Leblanc S, Gressel A, et al
MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival.
BMC Cancer. 2024;24:295.
PubMed Abstract available

MESHKANI Z, Moradi N, Aboutorabi A, Farabi H, et al
A cost-benefit analysis of genetic screening test for breast cancer in Iran.
BMC Cancer. 2024;24:279.
PubMed Abstract available

REN J, Chen W, Zhou Y, Sun J, et al
The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
BMC Cancer. 2024;24:278.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum